<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Strategies to improve retention in randomised trials - Gillies, K - 2021 | Cochrane Library</title> <meta content="Strategies to improve retention in randomised trials - Gillies, K - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000032.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Strategies to improve retention in randomised trials - Gillies, K - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000032.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.MR000032.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Strategies to improve retention in randomised trials" name="citation_title"/> <meta content="Katie Gillies" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="k.gillies@abdn.ac.uk" name="citation_author_email"/> <meta content="Anna Kearney" name="citation_author"/> <meta content="University of Liverpool" name="citation_author_institution"/> <meta content="Ciara Keenan" name="citation_author"/> <meta content="Centre for Evidence and Social Innovation" name="citation_author_institution"/> <meta content="Shaun Treweek" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Jemma Hudson" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Valerie C Brueton" name="citation_author"/> <meta content="Florence Nightingale Faculty of Nursing Midwifery and Palliative Care, King's College" name="citation_author_institution"/> <meta content="Thomas Conway" name="citation_author"/> <meta content="National University of Ireland Galway" name="citation_author_institution"/> <meta content="Andrew Hunter" name="citation_author"/> <meta content="National University of Ireland Galway" name="citation_author_institution"/> <meta content="Louise Murphy" name="citation_author"/> <meta content="National University of Ireland Galway" name="citation_author_institution"/> <meta content="Peter J Carr" name="citation_author"/> <meta content="National University of Ireland Galway" name="citation_author_institution"/> <meta content="Greta Rait" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Paul Manson" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Magaly Aceves-Martins" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.MR000032.pub3" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/03/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000032.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000032.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000032.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Case Management; Correspondence as Topic; Patient Compliance [psychology, *statistics &amp; numerical data]; Patient Dropouts [statistics &amp; numerical data]; Patient Selection; Randomized Controlled Trials as Topic [*statistics &amp; numerical data]; Reward; Surveys and Questionnaires" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000032.pub3&amp;doi=10.1002/14651858.MR000032.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="7LavyS58";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eMR000032\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eMR000032\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","pt","ko","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.MR000032.pub3",title:"Strategies to improve retention in randomised trials",firstPublishedDate:"Mar 6, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Methodology Review Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000032.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000032.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.MR000032.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.MR000032.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000032.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="MR000032.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.MR000032.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="MR000032.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.MR000032.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.MR000032.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8579 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.MR000032.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-sec-0041"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-sec-0011"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-sec-0012"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-sec-0035"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-sec-0039"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/appendices#MR000032-sec-0046"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/table_n/MR000032StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/table_n/MR000032StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Methodology</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Strategies to improve retention in randomised trials</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Katie Gillies</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0005">Anna Kearney</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0006">Ciara Keenan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0007">Shaun Treweek</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0008">Jemma Hudson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0009">Valerie C Brueton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0010">Thomas Conway</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0011">Andrew Hunter</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0012">Louise Murphy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0013">Peter J Carr</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0014">Greta Rait</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0015">Paul Manson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information#MR000032-cr-0016">Magaly Aceves-Martins</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information/en#MR000032-sec-0053">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 March 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.MR000032.pub3">https://doi.org/10.1002/14651858.MR000032.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="MR000032-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000032-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#MR000032-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000032-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000032-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#MR000032-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000032-abs-0005">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#MR000032-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="MR000032-abs-0001" lang="en"> <section id="MR000032-sec-0001"> <h3 class="title" id="MR000032-sec-0001">Background</h3> <p>Poor retention of participants in randomised trials can lead to missing outcome data which can introduce bias and reduce study power, affecting the generalisability, validity and reliability of results. Many strategies are used to improve retention but few have been formally evaluated. </p> </section> <section id="MR000032-sec-0002"> <h3 class="title" id="MR000032-sec-0002">Objectives</h3> <p>To quantify the effect of strategies to improve retention of participants in randomised trials and to investigate if the effect varied by trial setting. </p> </section> <section id="MR000032-sec-0003"> <h3 class="title" id="MR000032-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Scopus, PsycINFO, CINAHL, Web of Science Core Collection (SCI‐expanded, SSCI, CPSI‐S, CPCI‐SSH and ESCI) either directly with a specified search strategy or indirectly through the ORRCA database. We also searched the SWAT repository to identify ongoing or recently completed retention trials. We did our most recent searches in January 2020. </p> </section> <section id="MR000032-sec-0004"> <h3 class="title" id="MR000032-sec-0004">Selection criteria</h3> <p>We included eligible randomised or quasi‐randomised trials of evaluations of strategies to increase retention that were embedded in 'host' randomised trials from all disease areas and healthcare settings. We excluded studies aiming to increase treatment compliance. </p> </section> <section id="MR000032-sec-0005"> <h3 class="title" id="MR000032-sec-0005">Data collection and analysis</h3> <p>We extracted data on: the retention strategy being evaluated; location of study; host trial setting; method of randomisation; numbers and proportions in each intervention and comparator group. We used a risk difference (RD) and 95% confidence interval (CI) to estimate the effectiveness of the strategies to improve retention. We assessed heterogeneity between trials. We applied GRADE to determine the certainty of the evidence within each comparison. </p> </section> <section id="MR000032-sec-0006"> <h3 class="title" id="MR000032-sec-0006">Main results</h3> <p>We identified 70 eligible papers that reported data from 81 retention trials. We included 69 studies with more than 100,000 participants in the final meta‐analyses, of which 67 studies evaluated interventions aimed at trial participants and two evaluated interventions aimed at trial staff involved in retention. All studies were in health care and most aimed to improve postal questionnaire response. Interventions were categorised into broad comparison groups: Data collection; Participants; Sites and site staff; Central study management; and Study design. </p> <p>These intervention groups consisted of 52 comparisons, none of which were supported by high‐certainty evidence as determined by GRADE assessment. There were four comparisons presenting moderate‐certainty evidence, three supporting retention (self‐sampling kits, monetary reward together with reminder or prenotification and giving a pen at recruitment) and one reducing retention (inclusion of a diary with usual follow‐up compared to usual follow‐up alone). Of the remaining studies, 20 presented GRADE low‐certainty evidence and 28 presented very low‐certainty evidence. </p> <p>Our findings do provide a priority list for future replication studies, especially with regard to comparisons that currently rely on a single study. </p> </section> <section id="MR000032-sec-0007"> <h3 class="title" id="MR000032-sec-0007">Authors' conclusions</h3> <p>Most of the interventions we identified aimed to improve retention in the form of postal questionnaire response. There were few evaluations of ways to improve participants returning to trial sites for trial follow‐up. None of the comparisons are supported by high‐certainty evidence. Comparisons in the review where the evidence certainty could be improved with the addition of well‐done studies should be the focus for future evaluations. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="MR000032-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000032-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#MR000032-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000032-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000032-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#MR000032-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#MR000032-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000032-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#MR000032-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="MR000032-abs-0002" lang="en"> <h3>Strategies that might help to encourage people to continue to participate in a randomised trial (a type of scientific study) </h3> <p><b>Why is this review important?</b> </p> <p>Randomised trials are a type of scientific study typically used to test new healthcare treatments. In a randomised trial, people who agree to take part are randomly (by chance) put into one of two or more treatment groups and then studied for a period of time. The research team try to keep in touch with them to collect information about how they are doing. This 'follow up' can last from days to years depending on the trial, but the longer the trial lasts, the more difficult it can be. This might be because people are too busy to reply, are unable to come to a clinic, or just do not want to participate any longer. Keeping people in a trial is called 'retention'. If retention is poor, it can make the trial results less certain but most trials do not get data from all the people who started out in the trial. </p> <p>The information gathered during follow‐up, sometimes called data, helps the trial team to determine which of the treatments being tested works the best. Often this information is collected directly from patients by asking them to complete a questionnaire or by asking them to come back for a clinic visit. </p> <p>There are many ways to collect data from people in trials. These include using letters, the internet, telephone calls, text messaging, face‐to‐face meetings or the return of medical test kits. Research teams use different methods to try to collect data and it's important to know which strategies are effective and worthwhile, which is why we did this review to compare the success of different strategies. </p> <p><b>How did we identify and evaluate the evidence?</b> </p> <p>We searched scientific databases for studies that compared strategies that research teams use to improve trial retention against each other or against not using such a strategy.We looked for studies that included participants from any age, gender, ethnic, language or geographic group. We then compared the results of the studies, and summarised the evidence that we had found. Finally, we rated our confidence in this evidence, based on factors such as the methods used in the studies and their size, and the consistency of findings across studies. </p> <p><b>What did we find?</b> </p> <p>We identified 70 relevant articles, which reported 81 retention studies involving more than 100,000 participants, that had investigated different ways of trying to encourage randomised trial participants to provide data and stay in the trial. We organised these into broad comparison groups but, unfortunately, we are not able to say with confidence that any of the results we found is a true effect and not caused by other factors, such as flaws with the design of the studies. As such, the effect of ways to encourage people to stay involved in trials is still not clear and more research is needed to see if these retention methods really do work. </p> <p><b>How certain is the evidence and how up‐to‐date is this review?</b> </p> <p>The strategies we identified were tested in randomised trials run in many different disease areas and settings but, in some cases, were tested in only one trial. None of the comparisons we made provided high quality evidence and more studies are needed to help provide more confidence for the results we did find. The evidence in this Cochrane Review is current to January 2020. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="MR000032-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="MR000032-sec-0041"></div> <h3 class="title" id="MR000032-sec-0042">Implication for systematic reviews and evaluations of healthcare</h3> <section id="MR000032-sec-0042"> <p>Trialists should consider including well‐designed evaluations of strategies to increase retention in randomised trials. A focus on replication of existing interventions for which additional high‐quality evidence is required should be the priority rather than uncoordinated scattergun approaches to identify improvements. </p> </section> <h3 class="title" id="MR000032-sec-0043">Implication for methodological research</h3> <section id="MR000032-sec-0043"> <p>There are key recommendations for methodological research in this area.</p> <p><b>Prioritisation:</b> this is important both in terms of replication of existing studies and development and evaluation of interventions for priority questions. With regard to replication of existing studies, we believe there are three categories consisting of eight interventions in total that could immediately benefit from further research. These are presented below in order of priority. Decisions about whether further evaluation is required have been guided by <a href="./references#MR000032-bbs2-0209" title="TreweekS , BevanS , BowerP , BrielM , CampbellM , ChristieJ , et al. Trial Forge Guidance 2: How to decide if a further Study Within A Trial (SWAT) is needed. Trials2020;21:33. [DOI: 10.1186/s13063-019-3980-5]">Treweek 2020b</a>, but are largely based on the fact that none of these comparisons have high GRADE certainty in the evidence. </p> <p>Category A – interventions with multiple existing evaluations that currently provide low‐certainty evidence but rigorous replication could move the evidence up to moderate or high certainty. These are presented in order of effect size from highest (7%) to lowest (1%), which also corresponds with the predicted cost of each. </p> <p>1. Monetary incentive compared to no incentive.</p> <p>2. Return postage strategies (e.g. such as free post versus second class stamp; high‐priority mail stamp versus usual postage; and personal form) compared to usual practice for return postage. </p> <p>3. Addition of a pen versus no pen.</p> <p>4. Electronic reminders compared to usual follow‐up.</p> <p>Two other interventions were identified that fulfilled this criterion, but which may have a detrimental effect on retention and have therefore not been prioritised for further evaluations at this stage: Personalised prompts compared to no prompt, and inclusion of a diary in addition to normal follow‐up. </p> <p>Category B – interventions with multiple existing evaluations but which together currently provide low‐ or very low‐certainty evidence and which are nevertheless likely to be in routine use. </p> <p>5. Post‐it note compared to no post‐it note or alternative post‐it notes (e.g. printed versus handwritten). </p> <p>6. Newsletter compared to no newsletter.</p> <p>Category C ‐ interventions currently with a single evaluation but which provide moderate‐certainty evidence and large potential effect sizes (RD 20% and 9%, respectively), are relatively easy to implement and may be cheap to implement. </p> <p>7. Giving a pen at recruitment.</p> <p>8. Addition of monetary rewards to both trial arms.</p> <p>One further intervention (use of self‐sampling kits (directly mailed or an invitation to order)) also had moderate‐certainty evidence of benefit for retention but given it would only be of relevance for a small sub‐set of trials, it was judged to be of lower priority than the other two. </p> <p>In addition to these replications, the questions identified in the PRioRiTY II project (which aimed to identify the unanswered questions for trial retention research) should act as a guiding framework to enable research teams to develop interventions to improve retention for which there is community buy‐in and desire for evidence (<a href="./references#MR000032-bbs2-0186" title="BrunsdonD , BiestyL , BrocklehurstP , BruetonV , DevaneD , ElliottJ , et al. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study. Trials2019;20(1):593. [DOI: 10.1186/s13063-019-3687-7]">Brunsdon 2019</a>). For example, questions in the Top 10 do consider impacts on trial staff, yet only two of the 68 studies included in this review evaluated strategies targeting staff. Likewise, retention behaviours that go beyond participants returning a trial questionnaire, such as attending a follow‐up clinic, also warrant evaluation. </p> <p><b>Design:</b> well‐designed retention trials that are considered from the design stage of the host trial are also key. Ensuring appropriate detail in terms of process and intervention are critical for timely replication. As a minimum, SWATs should have a publicly available outline registered on the SWAT repository (<a href="./references#MR000032-bbs2-0207" title="SWAT repository. www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/SWATSWARInformation/Repositories/SWATStore/ Accessed on 1 December 2020.">SWAT</a>). </p> <p><b>Reporting:</b> retention trials were often poorly reported, without CONSORT flow diagrams, clear primary outcomes, sample size, and sociodemographic composition. In the context of this review, this meant that we had to contact authors for unreported data that we needed for robust meta‐analyses. Trialists writing their reports should adhere to CONSORT guidelines for trial reporting (<a href="./references#MR000032-bbs2-0198" title="MoherD , HopewellS , SchulzKF , MontoriV , GøtzschePC , DevereauxPJ , et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c869. [DOI: 10.1136/bmj.c869] [PMID: 20332511]">Moher 2010</a>), which would facilitate the synthesis of results in future methodology reviews. Guidance for reporting embedded recruitment trials have been developed and these could also serve as a set of guiding principles when reporting embedded retention trials (<a href="./references#MR000032-bbs2-0197" title="MadurasingheVW , EldridgeS , on behalf of MRC START Group and Gordon Forbes on behalf of the START Expert Consensus Group. Guidelines for reporting embedded recruitment trials. Trials2016;17:27. [DOI: doi.org/10.1186/s13063-015-1126-y]">Madurasinghe 2016</a>). Furthermore, clarity on the intention of interventions with regard to their proposed mechanism of action and reporting on all key aspects (for example using the TiDier framework (<a href="./references#MR000032-bbs2-0195" title="HoffmannTC , GlasziouPP , BoutronI , MilneR , PereraR , MoherD , et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ2014;348:g1687. [DOI: doi.org/10.1136/bmj.g1687]">Hoffman 2014</a>)) is important for future replication and, when available, implementation of effective strategies. </p> <p><b>Context:</b> linked to prioritisation, it is important to consider which areas in terms of trial populations and contexts need more attention. The majority of the trials included in this review included white adults in non‐emergency settings who were able to consent for themselves in high‐income countries. Research to understand whether the findings from interventions shown to be effective in this population translate into other settings (e.g. in people from ethnic backgrounds, paediatric trials, emergency care trials, and trials in adults who lack capacity and other underserved groups).This additional contextual information is essential for making informed decisions about whether further replication studies are required (<a href="./references#MR000032-bbs2-0209" title="TreweekS , BevanS , BowerP , BrielM , CampbellM , ChristieJ , et al. Trial Forge Guidance 2: How to decide if a further Study Within A Trial (SWAT) is needed. Trials2020;21:33. [DOI: 10.1186/s13063-019-3980-5]">Treweek 2020b</a>). </p> <p><b>Collaboration:</b> in order to generate evidence on what interventions do, or do not improve retention, there needs to be coordinated collaboration to enable key questions to be answered in a timely fashion. This is of critical importance. The current approach is more scattergun than targeted. Ongoing efforts such as the <a href="./references#MR000032-bbs2-0200" title="PROMETHEUS. https://www.york.ac.uk/healthsciences/research/trials/research/swats/prometheus/.">PROMETHEUS</a> project and <a href="./references#MR000032-bbs2-0210" title="Trial Forge - A systematic way to improve trial efficiency. wwww.trialforge.org.">Trial Forge</a> aim to offer support (both in terms of advice but also tools such as text for ethics applications etc) for trial teams conducting SWATs and encourage parallel evaluations of interventions across a range of trials. Funders also have a role to play and whilst recent times have seen a shift to funds being available to support SWATs (especially in the UK and Ireland), a move to commissioned calls to evaluate priority SWAT interventions might accelerate the evidence generation for priority topics. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="MR000032-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="MR000032-sec-0008"></div> <div class="table" id="MR000032-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Questionnaire design: short vs usual questionnaire</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short questionnaire compared with long questionnaire for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> short questionnaire </p> <p><b>Comparison:</b> usual questionnaire </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Short questionnaire</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual questionnaire</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>As measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.01</b> (0.89 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3252<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(22 to 29 ) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(45 to 57) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 100</b><br/>(71 to 91) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of a short questionnaire</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Questionnaire design: addition of diary to usual follow‐up vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Addition of diary to usual follow‐up compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> diary </p> <p><b>Comparison:</b> no diary </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Diary</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No diary</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.97</b> (0.96 to 0.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>9906<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 100</b><br/>(24 to 25) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 100</b><br/>(48 to 49) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>78 per 100</b><br/>(77 to 78) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of not including a diary</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup>We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Data collection location and method: telephone follow‐up vs postal questionnaire</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Telephone follow‐up compared with postal questionnaire for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> telephone follow‐up </p> <p><b>Comparison:</b> postal questionnaire </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Telephone follow‐up</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Postal questionnaire</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.04</b> (0.94 to 1.17) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1006<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(24 to 29) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>52 per 100</b><br/>(47 to 59) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 100</b><br/>(75 to 94) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of telephone follow‐up</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Data collection location and method: return postage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Return postage compared with control intervention for trial retention</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> various return postage strategies </p> <p><b>Comparison:</b> control intervention </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p>Various return postage strategies <b>(such as free post versus second class stamp; high priority mail stamp versus usual postage; and personal form)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard return postage</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.06</b> (0.99 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1543<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 100</b><br/>(25 to 29) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>53 per 100</b><br/>(50 to 58) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 100</b><br/>(79 to 92) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Reminders: electronic reminder vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Electronic reminder compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> electronic reminder </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Electonic reminder</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.01</b> (0.95 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>790<br/>(3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(24 to 27) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(48 to 55) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 100</b><br/>(76 to 87) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of an electronic reminder</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Prompts: Electronic prompt vs no prompt</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Electronic prompt compared with no prompt for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> electronic prompt </p> <p><b>Comparison:</b> no prompt </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Electronic prompt</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No prompt</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.03</b> (0.98 to 1.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>2897<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(25 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>52 per 100</b><br/>(49 to 54) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(78 to 86) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of electronic prompts</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Prompts: Telephone prompt vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Telephone prompt compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> telephone prompt </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Telephone prompt</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.02</b> (0.85 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>943<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(21 to 31) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(43 to 61) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(68 to 98) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of telephone prompts</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Prompts: personalised prompt vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Personalised prompt compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> personalised prompt </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Personalised prompt</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.97</b> (0.89 to 1.07) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>701<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 100</b><br/>(22 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 100</b><br/>(45 to 54) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>78 per 100</b><br/>(71 to 86) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of personalised prompts</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Monetary incentives: addition of monetary incentives vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Addition of monetary incentives compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> monetary incentives </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary incentives</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.20</b> (1.06 to 1.36) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3166<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 100</b><br/>(27 to 34) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b><br/>(53 to 68) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>96 per 100</b><br/>(85 to [109) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of monetary incentives</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0010"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Monetary incentives: addition of monetary incentives vs addition of a monetary reward</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Addition of monetary incentives compared with addition of a monetary reward for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> monetary incentive </p> <p><b>Comparison:</b> monetary reward </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary incentive</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary reward</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.00</b> (0.91 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3765<br/>(4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(23 to 28) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b><br/>(46 to 55) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b><br/>(73 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0011"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Monetary incentives: addition of monetary reward vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Addition of monetary reward compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> monetary reward </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary reward</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.02</b> (0.96 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1159<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(24 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(48 to 55) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(77 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of monetary reward</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0012"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Non‐monetary incentives: addition of pen vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Pen compared with no pen for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> pen </p> <p><b>Comparison:</b> no pen </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Pen</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No pen</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.02</b> (1.00 to 1.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>13013<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(25 to 26) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>50 to 53) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(80 to 84) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0013"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">Maintaining participant engagement: newsletter vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Newsletter compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> newsletter </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Newsletter</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.99</b> (0.95 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>5622<br/>(4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(24 to 26) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b><br/>(48 to 52) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 100</b><br/>(76 to 83) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0014"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">Maintaining participant engagement: post‐it note vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Post‐it note compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> post‐it note </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Post‐it note</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.00</b> (0.99 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>4698<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(25 to 25) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b><br/>(50 to 51) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b><br/>(79 to 81) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of a post‐it note</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0015"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">Behavioural interventions: theory informed cover letter vs usual cover letter</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Theory informed cover letter compared with usual cover letter for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> theory informed cover letter </p> <p><b>Comparison:</b> usual cover letter </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Theory informed cover letter</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual cover letter</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.05</b> (0.98 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3343<br/>(4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(25 to 28) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>53 per 100</b><br/>(49 to 56) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 100</b><br/>(78 to 90) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of a theory informed cover letter</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0016"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 16.</span> <span class="table-title">Impact of recruitment: optimised information vs standard information</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Addition of optimised information compared with standard information for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> optimised patient information leaflet (PIL) </p> <p><b>Comparison:</b> standard PIL </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Optimised PIL</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard PIL</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.96</b> (0.85 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1285<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 100</b><br/>(21 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 100</b><br/>(43 to 55) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 100</b><br/>(68 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="MR000032-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="MR000032-sec-0009"></div> <p>Randomised trials are considered the gold standard for evaluating the effectiveness and efficacy of interventions. Poor retention (or high attrition) in randomised trials has serious consequences for the validity, reliability and usability of their results. Missing data, resulting from poor retention, are of particular concern if the data that are not missing are not at random. In other words, if there is a difference in the amount of missing data between the trial arms or amongst people who are more unwell. However, even if data are missing at random, this is also a potential problem because it will weaken the power of the trial and mean that more participants are needed to achieve a satisfactory sample size. It has been proposed that loss of less than 5% is not problematic but that more than 20% is a serious threat to validity, with anything in between also requiring attention (<a href="./references#MR000032-bbs2-0190" title="FewtrellMS , KennedyK , SinghalA , MartinRM , NessA , Hadders-AlgraM , et al. How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?Archives of Disease in Childhood2008;93(6):458-61.">Fewtrell 2008</a>; <a href="./references#MR000032-bbs2-0204" title="SchulzKF , GrimesDA . Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet2002;359(9308):781-5.">Schulz 2002</a>). Recent work suggests that up to 50% of all trials have loss to follow‐up of more than 11% (<a href="./references#MR000032-bbs2-0213" title="WaltersSJ , Bonacho Dos Anjos Henriques-CadbyI , BortolamiO , FlightL , HindD , JacquesRM , et al. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open2017;7:3. [DOI: 10.1136/bmjopen-2016-015276]">Walters 2016</a>). </p> <p>Missing data from loss to follow‐up can be dealt with statistically by various methods including, for example, imputing values based on assumptions about the missing data to give a conservative estimate of the treatment effect (methods such as maximum likelihood estimation routines or multiple imputation). However, the risk of bias still remains when trials do not collect adequate data to give accurate estimates (<a href="./references#MR000032-bbs2-0196" title="HollisS , CampbellF . What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ1999;319(7211):670-4.">Hollis 1999</a>). Loss to follow‐up from randomised trials can sometimes go unreported and using different, but plausible, assumptions about outcomes for participants lost to follow‐up can change the results of randomised trials (<a href="./references#MR000032-bbs2-0211" title="WalshM , SrinathanSK , McAuleyDF , MrkobradaM , LevineO , RibicC , et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. Journal of Clinical Epidemiology2014;67(6):622-8. [DOI: 10.1016/j.jclinepi.2013.10.019]">Walsh 2014</a>). However, rather than adjusting for missingness in the analysis of a trial, and inflating the sample size during recruitment, it seems much more sensible to mitigate the problem of poor retention by designing and evaluating approaches and strategies to maximise data collection. Not knowing how best to retain people in trials means trials will take longer (and cost more) and may expose additional patients to unnecessary risk or forgo the opportunity for others to receive effective treatments. Evidence for effective retention strategies would enable trial teams to include strategies in their trial which are likely to maximise trial design, efficiency and reduce research waste. </p> <p>This is a substantially revised update of the first full version of this Cochrane Methodology Review (<a href="./references#MR000032-bbs2-0215" title="BruetonVC , TierneyJ , StenningS , HardingS , MeredithS , NazarethI , et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: MR000032. [DOI: 10.1002/14651858.MR000032.pub2]">Brueton 2013</a>). The scope of this review is restricted to interventions that are designed to maximise data collection from trial participants once they have been recruited and randomised. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines define non‐retention as instances in which participants are prematurely ’off‐study’ (i.e. consent withdrawn or lost to follow‐up), and therefore outcome data cannot be obtained (<a href="./references#MR000032-bbs2-0187" title="Chan A-W, TetzlaffJM , AltmanDG , DickersinK , MoherD . SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet2013;381(9861):91-2. [DOI: 10.1016/S0140-6736(12)62160-6.]">Chan 2013</a>). However, participants can still be 'on‐study' but not provide outcome data. Trial non‐retention is distinct from non‐adherence to the trial intervention, which refers to the degree to which the behaviour of trial participants corresponds to the intervention assigned to them. There are Studies Witihin A Trial (SWAT) for this (<a href="./references#MR000032-bbs2-0184" title="BensaaudA , GibsonI , JonesJ , FlahertyG , SultanS , TawfickW , JordanF . A telephone reminder to enhance adherence to interventions in cardiovascular randomized trials: a protocol for a study within a trial (SWAT). Journal of Evidence-based Medicine2020;13(1):81-4. [DOI: 10.1111/jebm.12375]">Bensaaud 2020</a>), but it is not within the scope of this review. </p> <section id="MR000032-sec-0010"> <h3 class="title" id="MR000032-sec-0010">Description of the methods being investigated</h3> <p>Strategies to improve trial retention include those designed to generate maximum data return or compliance and follow‐up procedures that aim to collect data from participants (e.g. weight measurements, blood tests). These strategies can include how outcomes are collected (e.g. postal or telephone); who collects outcomes (e.g. participant‐reported or routine data), when outcomes are collected and also consider, where outcomes are collected (e.g. postal questionnaire or clinic visits). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="MR000032-sec-0011" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="MR000032-sec-0011"></div> <p>To quantify the effects of strategies for improving retention of participants in randomised trials. A secondary objective is to investigate if the effects vary by trial setting. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="MR000032-sec-0012" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="MR000032-sec-0012"></div> <section id="MR000032-sec-0013"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="MR000032-sec-0014"> <h4 class="title">Types of studies</h4> <p>Randomised and quasi‐randomised trials of interventions to improve retention of participants in randomised trials (hereafter referred to as retention trials). </p> <p>Strategies to improve retention are designed to have an impact after participants are randomised to one of the intervention groups of the host and the retention trial, however, they could be delivered at any point (including at the time of recruitment, for example by modifying the information that focuses on retention that is presented to potential participants). Participants in the host trials cover a range of groups and can include (but not be limited to): patients, public, healthcare professionals, etc, and likewise the retention trials might include a range of designs such as individually‐randomised, cluster‐randomised, etc. We excluded trials of strategies that were intended to increase recruitment only, because these are covered by a complementary Cochrane Methodology Review (<a href="./references#MR000032-bbs2-0208" title="TreweekS , PitkethlyM , CookJ , FraserC , MitchellE , SullivanF , et al. Strategies to improve recruitment to randomised trials. Cochrane Database of Systematic Reviews2018, Issue 2. Art. No: MR000013. [DOI: 10.1002/14651858.MR000013.pub6]">Treweek 2018</a>). We excluded cohort studies with embedded randomised retention trials, which are the subject of a separate systematic review (<a href="./references#MR000032-bbs2-0185" title="BookerC , HardingS , BenzevalM . A systematic review of the effect of retention methods on response rates in population-based cohort studies. BMC Public Health.2011;11:249.">Booker 2011</a>). </p> <p>When referring to embedded trials, we mean randomised trials of retention interventions (e.g. monetary incentives to improve response to postal questionnaires) that are set within a clinical trial (e.g. drug treatment for stroke). Clinical trials that embed retention trials are sometimes referred to as the host trial. Embedded trials are also sometimes referred to as Studies Within A Trial or SWATs. As per guidance by <a href="./references#MR000032-bbs2-0208" title="TreweekS , PitkethlyM , CookJ , FraserC , MitchellE , SullivanF , et al. Strategies to improve recruitment to randomised trials. Cochrane Database of Systematic Reviews2018, Issue 2. Art. No: MR000013. [DOI: 10.1002/14651858.MR000013.pub6]">Treweek 2018</a>, ‘a SWAT is a self‐contained research study that has been embedded within a host trial with the aim of evaluating or exploring alternative ways of delivering or organising a particular trial process’. </p> </section> <section id="MR000032-sec-0015"> <h4 class="title">Types of data</h4> <p>We included retention trials within the context of a host randomised trial with participants from any age, gender, ethnic, language and geographic groups. We included unpublished and published participant retention data from randomised trials addressing health care (including all disciplines and disease areas) and non‐healthcare (education, social sciences) topics. We also included trials set in the community that were healthcare‐related. However, whilst the setting could be non‐health care, the outcomes being measured in the host randomised trial were required to be clinical‐ or health‐related. The retention trials were embedded in real trials (host trials) and not hypothetical trials. </p> </section> <section id="MR000032-sec-0016"> <h4 class="title">Types of methods</h4> <p>Any intervention that aimed to improve retention of participants to a randomised trial. We considered any strategy aimed at increasing retention, whether it was directed towards the clinician, researcher or participant. The retention trials included at least one randomised comparison of two or more strategies to improve retention, or compared one or more strategies with usual study procedures. We also included trials with any combination of strategies to increase retention. Strategies could include any of the following: </p> <p> <ul id="MR000032-list-0001"> <li> <p>data collection (e.g. shorter length of follow‐up or variation in follow‐up visit frequency); </p> </li> <li> <p>participant strategies (e.g. monetary incentives, non‐monetary incentives, reminders, behavioural strategies, etc); </p> </li> <li> <p>sites and site staff (e.g. monitoring approaches);</p> </li> <li> <p>central study management (e.g. patient and public involvement);</p> </li> <li> <p>study design (e.g. blinding and treatment preference).</p> </li> </ul> </p> <p>For trials that simultaneously evaluated more than one intervention, unless designed as a factorial trial, or interaction effects were accounted for in the analysis, interventions had to be separated by at least six months to be considered eligible for the review. The reason for this was to account for contamination effects from carry over of previous intervention effects. </p> </section> <section id="MR000032-sec-0017"> <h4 class="title">Types of outcome measures</h4> <section id="MR000032-sec-0018"> <h5 class="title">Primary outcomes</h5> <p>The proportion of participants retained at the primary analysis point as defined in each individual retention trial is our primary outcome. If the primary outcome was not predefined in a retention trial, we took the first time point reported for analysis. In most cases, this was final response. If retention at a number of time points was reported and no clear time point for the primary outcome for the retention trial was stated, we took data for the nearest time point to the intervention in the retention trial analyses. For studies that reported data captured 'without additional chasing' (i.e. no further standard follow‐up processes such as telephone calls were included before data collection), this was selected as the primary analysis point for data to be included in this review. For studies that delivered an intervention at trial recruitment, we took the total number of participants in the intervention trial as the number who consented as the denominator and the number retained as the numerator. All decisions about primary outcome timing were based on the retention trial publication and discussion within our team; we did not check study protocols or contact authors for clarification. </p> </section> <section id="MR000032-sec-0019"> <h5 class="title">Secondary outcomes</h5> <p>This update includes no secondary outcomes. This is a change from the previous version of the review (<a href="./references#MR000032-bbs2-0215" title="BruetonVC , TierneyJ , StenningS , HardingS , MeredithS , NazarethI , et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: MR000032. [DOI: 10.1002/14651858.MR000032.pub2]">Brueton 2013</a>) which stated "Retention of participants at secondary analysis points" as a secondary outcome. However, because this is rarely reported, we decided to no longer include it as a secondary outcome. </p> </section> </section> </section> <section id="MR000032-sec-0020"> <h3 class="title">Search methods for identification of studies</h3> <p>We used the Online Resource for Recruitment research in Clinical triAls (ORRCA, www.orrca.org.uk) database to search for studies that had been published up to the end of December 2017. As the scope of this update had changed from that of the original review (<a href="./references#MR000032-bbs2-0215" title="BruetonVC , TierneyJ , StenningS , HardingS , MeredithS , NazarethI , et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: MR000032. [DOI: 10.1002/14651858.MR000032.pub2]">Brueton 2013</a>), we re‐ran the full search from database inception rather than only for the period required for the update (which would have been 2013 to 2020). The ORRCA database provides a comprehensive online database of published research (empirical and non‐empirical) about recruitment and/or retention to clinical research. ORRCA is populated from an extensive systematic search of the Cochrane Library, MEDLINE (Ovid), SCOPUS, CINAHL, psycINFO, and SCI‐EXPANDED and SSCI (via ISI Web of Science). The search strategy used to populate ORRCA was based on the original Cochrane Review of strategies to improve trial retention (<a href="./references#MR000032-bbs2-0215" title="BruetonVC , TierneyJ , StenningS , HardingS , MeredithS , NazarethI , et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: MR000032. [DOI: 10.1002/14651858.MR000032.pub2]">Brueton 2013</a>), but updated and extended to ensure capture of all relevant studies in this area (see below and Appendices for details). Eligible articles are categorised on the ORRCA database according to research methods and host study characteristics. We searched the ORRCA retention database in April 2020 to identify randomised evaluations of retention strategies that were nested within randomised trials (including factorial, cluster and cross‐over trials), patient preference studies, registries or where the host study type was unknown. </p> <p>The search strategy used to develop ORRCA aimed to identify published research addressing retention challenges in healthcare and social science settings involving any method of follow‐up. At the time of updating this review, ORRCA only captured studies published until January 2018. Therefore we also ran the search strategy across all platforms described above, to capture studies published between January 2018 and January 2020. </p> <section id="MR000032-sec-0021"> <h4 class="title">Electronic searches</h4> <p>Each search comprised a filter to identify randomised trials plus free‐text terms and database subject headings relating to reducing loss to follow‐up or increasing retention (<a href="./appendices#MR000032-sec-0047">Appendix 1</a>). Electronic databases that we searched included the following. </p> <p> <ul id="MR000032-list-0002"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (to January 2020)</p> </li> <li> <p>MEDLINE (OVID) (1950 to January 2020) (<a href="./appendices#MR000032-sec-0047">Appendix 1</a>) </p> </li> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health; 1981 to January 2020) (<a href="./appendices#MR000032-sec-0047">Appendix 1</a>) </p> </li> <li> <p>PsycINFO (1806 to January 2020) (<a href="./appendices#MR000032-sec-0047">Appendix 1</a>) </p> </li> <li> <p>SCOPUS (to January 2020)</p> </li> <li> <p>Web of Science Core Collection (SCI‐expanded, SSCI, CPSI‐S, CPCI‐SSH and ESCI) (1900 to January 2020) </p> </li> </ul> </p> </section> <section id="MR000032-sec-0022"> <h4 class="title">Searching other resources</h4> <p>We also searched the SWAT repository (<a href="./references#MR000032-bbs2-0207" title="SWAT repository. www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/SWATSWARInformation/Repositories/SWATStore/ Accessed on 1 December 2020.">SWAT</a>) to identify retention trials that were unpublished or ongoing. </p> </section> </section> <section id="MR000032-sec-0023"> <h3 class="title" id="MR000032-sec-0023">Data collection and analysis</h3> <section id="MR000032-sec-0024"> <h4 class="title">Selection of studies</h4> <p>All review authors were involved in the screening of titles and abstracts retrieved by the searches (in batches of 600) using a predesigned study eligibility screening form. A random 10% of each batch and all potentially eligible titles and abstracts were double screened by one of the review team (KG). We obtained full‐text papers for all potentially eligible studies for inclusion. All review authors were involved in independently assessing full‐text articles to determine if they fulfilled the inclusion criteria, with two review authors allocated to each full‐text article. We contacted study authors for electronic copies of papers that we could not access through library sources. We were able to obtain copies of all the potentially eligible papers, or abstracts, that we wanted to screen. When necessary, we sought information from the original investigators for potentially eligible trials where we wished to clarify eligibility. We resolved disagreements by discussion with a third review author (MAM or KG). </p> </section> <section id="MR000032-sec-0025"> <h4 class="title">Data extraction and management</h4> <p>All review authors were involved in independently extracting data from included studies using a prespecified data extraction form, with two review authors allocated to each study. A third review author (MAM) checked the extractions for inconsistencies and any discrepancies were resolved by discussion with another review author (KG). Data extracted for the host trial were: design, location, setting, population, intervention, and comparator. For the embedded retention trial, we extracted data on: randomised or quasi‐randomised; design; aim; definition of retention used; retention period; the source of the retention trial sample (e.g. all host participants, participants lost to follow‐up, etc), and participant details. The retention strategy details extracted included: type, theoretically based; description; frequency and timing; mode of delivery; co‐interventions; economic information; resource requirements, numbers and proportions of participants in the intervention and comparator groups of the retention trial. </p> </section> <section id="MR000032-sec-0026"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>All included studies (from previous version of review (n = 32) and this update (n = 39)) were assessed independently by two review authors (KG and MAM or ST) for risk of bias using the Cochrane 'Risk of bias' tool (<a href="./references#MR000032-bbs2-0193" title="HigginsJP , AltmanD . Chapter 8: Assessing risk of bias in included studies. In: HigginsJP , GreenS , editors(s). Cochrane Handbook of Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons, 2008:188-241.">Higgins 2008a</a>), with any disagreements being resolved by a third member of the review team (ST or MAM). Information on risk of bias for all included studies is presented in the <a href="./references#MR000032-sec-0058" title="">Characteristics of included studies</a> table. When assessing studies on 'Blinding of participants and/or personal', we determined that if study authors noted that participants/personnel were not able to be blinded but that they were not given explicit knowledge of the retention trial and/or there was no way staff could use this knowledge to influence the objective outcome of retention, we determined these to be of low risk of bias for this domain. Likewise, when assessing 'Blinding of outcome assessment' we made a judgement as to whether the lack of blinding of outcome assessors would impact on their assessment of the objective outcome of retention. For the majority assessed, we considered studies to be low risk of bias on this domain. If studies were scored as low risk of bis on any one element, or unclear on any one element, this was the corresponding overall risk of bias rating. </p> <p>We applied GRADE to all comparisons, including when only one study was available for a comparison (<a href="./references#MR000032-bbs2-0191" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck?YtterY , Alonso?CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336:924-6. [DOI: 10.1136/bmj.39489.470347.AD]">Guyatt 2008</a>). For meta‐analyses, GRADE assessment data for the relevant meta‐analyses are provided in the relevant 'Summary of findings' table. </p> <p>For single studies, we used the rules applied in the Cochrane recruitment review (<a href="./references#MR000032-bbs2-0208" title="TreweekS , PitkethlyM , CookJ , FraserC , MitchellE , SullivanF , et al. Strategies to improve recruitment to randomised trials. Cochrane Database of Systematic Reviews2018, Issue 2. Art. No: MR000013. [DOI: 10.1002/14651858.MR000013.pub6]">Treweek 2018</a>), with all studies initially assigned a high GRADE rating of certainty, with the following rules then applied to determine the overall rating. </p> <p> <ul id="MR000032-list-0003"> <li> <p>Study limitations: downgrade all studies at high risk of bias by two levels; downgrade all studies at uncertain risk of bias by one level. </p> </li> <li> <p>Inconsistency: assume no serious inconsistency.</p> </li> <li> <p>Indirectness: assume no serious indirectness (all studies provided direct retention data). </p> </li> <li> <p>Imprecision: downgrade all single studies by one level because of the sparsity of data; downgrade by a further level if the confidence interval is wide and includes a risk difference of zero. </p> </li> <li> <p>Reporting bias: assume no serious reporting bias.</p> </li> </ul> </p> <p>We provided an informative statement with each GRADE assessment following the guidance in GRADE Guideline 26 (<a href="./references#MR000032-bbs2-0203" title="SantessoN , GlentonC , DahmP , GarnerP , AklEA , AlperB , et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. Journal of Clinical Epidemiology2020;119:126-35. [DOI: 10.1016/j.jclinepi.2019]">Santesso 2020</a>). This uses both the GRADE assessment and the effect size to produce an informative statement. We used the following rules regarding effect size. </p> <p> <ul id="MR000032-list-0004"> <li> <p>Large effect: 10% or over</p> </li> <li> <p>Moderate effect: 5% to 9%</p> </li> <li> <p>Small important effect: 2% to 4%</p> </li> <li> <p>Trivial, small unimportant effect or no effect: 0% to‐ 1%</p> </li> </ul> </p> <p>We applied the same rules to effect size, regardless of whether the effect was an increase or a decrease in retention. </p> <p>As per the Cochrane recruitment review (<a href="./references#MR000032-bbs2-0208" title="TreweekS , PitkethlyM , CookJ , FraserC , MitchellE , SullivanF , et al. Strategies to improve recruitment to randomised trials. Cochrane Database of Systematic Reviews2018, Issue 2. Art. No: MR000013. [DOI: 10.1002/14651858.MR000013.pub6]">Treweek 2018</a>), we did not exclude studies that were assessed to be at high risk of bias. However, where a high risk of bias study is the only study in a comparison, we do not describe them in the Results or Discussion sections due to the low confidence we have in their findings. We encourage more rigorous evaluations of these interventions but would discourage interpretation about their effects on retention from existing evaluations. The exception to this is if the data from high risk of bias studies could be included in a meta‐analysis alongside data from other studies and where a cumulative judgement on the certainty of the body of evidence using GRADE (as described above) could then be done. </p> </section> <section id="MR000032-sec-0027"> <h4 class="title">Measures of the effect of the methods</h4> <p>We calculated risk difference (RD) and 95% confidence intervals (CIs) for retention to determine the effect of strategies on this outcome. </p> </section> <section id="MR000032-sec-0028"> <h4 class="title">Unit of analysis issues</h4> <p>For retention trials that randomised individuals and clusters, the unit of analysis was the participant. For cluster‐randomised trials that ignored clustering in the analysis, we inflated the standard errors (SEs) to avoid over precise estimates of effect as follows (<a href="./references#MR000032-bbs2-0194" title="HigginsJPT , DeeksJJ , Altman DG (editors). Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons, 2008:482-529.">Higgins 2008b</a>). </p> <p> <ol id="MR000032-list-0005"> <li> <p>We calculated the RD, 95% CI and SE based on participants in the usual way (i.e. ignoring clustering). </p> </li> <li> <p>This SE was then inflated using the design effect to get an adjusted SE: adjusted SE = SE X√ design effect. With the design effect calculated as follows: design effect = 1 + (M ‐ 1) Intra‐cluster coefficient (ICC) where M = mean cluster size, ICC = the intracluster correlation coefficient. </p> </li> <li> <p>Where published ICCs were not available, we used the mean ICC from appropriate external estimates for <a href="./references#MR000032-bbs2-0040" title="LandSR , RitterMW , CostantinoJP , JulianTB , CroninWM , HaileSR , et al. Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches. Journal of Clinical Oncology2007;25(32):5113-20. [DOI: 10.1200/jco.2007.12.1749]">Land 2007</a>. This was the mean of estimates for the return of EuroQol questionnaires (ICC = 0.054) from a source recommended by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Section 16.3.4) (<a href="./references#MR000032-bbs2-0194" title="HigginsJPT , DeeksJJ , Altman DG (editors). Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons, 2008:482-529.">Higgins 2008b</a>) and <a href="http://www.abdn.ac.uk/hsru/documents/iccs-web.xls" target="_blank">www.abdn.ac.uk/hsru/documents/iccs-web.xls</a> (last accessed 24 November 2020). </p> </li> <li> <p>We entered the effect estimate and the new updated SE into Review Manager 5 using the generic inverse variance (<a href="./references#MR000032-bbs2-0201" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.">RevMan 2012</a>). </p> </li> </ol> </p> <p>Where the number of participants randomised was not clearly stated in the included study report, we contacted the study authors for this information. </p> </section> <section id="MR000032-sec-0029"> <h4 class="title">Dealing with missing data</h4> <p>For unpublished studies, we contacted study authors for data for the'R risk of bias' assessment, numbers randomised to each group and numbers retained in each group at the primary endpoint. </p> </section> <section id="MR000032-sec-0030"> <h4 class="title">Assessment of heterogeneity</h4> <p>We agreed the presence of heterogeneity of the intervention effect where the Chi<sup>2</sup> statistic has a significance level of 0.10 (representing a 10% chance of a Type I error). This figure was chosen as it counterbalances the relatively low power of the test. We also used the I² test (<a href="./references#MR000032-bbs2-0192" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). It represents the total variation across studies and is unlike the Chi<sup>2</sup> test in that it is independent from the number of studies. Instead theI² is based on treatment effect. Heterogeneity was also explored through subgroup analyses. </p> </section> <section id="MR000032-sec-0031"> <h4 class="title">Assessment of reporting biases</h4> <p>We would have assessed reporting bias using tests for funnel plot asymmetry if sufficient data were available (<a href="./references#MR000032-bbs2-0189" title="EggerM , SmithGD , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>; <a href="./references#MR000032-bbs2-0206" title="SterneJ , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: HigginsJP , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons, 2008:297-333.">Sterne 2008</a>). </p> </section> <section id="MR000032-sec-0032"> <h4 class="title">Data synthesis</h4> <p>We grouped included trials based on the type of intervention under investigation with groups directly informed by the ORRCA retention domains (https://www.orrca.org.uk/Uploads/ORRCA_Retention_Domains.pdf). We added a further domain within the 'Participants' domain to allow separate consideration of prompts and reminders targeting retention. This classification resulted in five broad categories with intervention functions grouped within them. </p> <p> <ol id="MR000032-list-0006"> <li> <p>Data collection (Category A), interventions include:</p> <ol id="MR000032-list-0007"> <li> <p>questionnaire design;</p> </li> <li> <p>data collection frequency/timing;</p> </li> <li> <p>data collection location and method.</p> </li> </ol> </li> <li> <p>Participants (Category B), interventions include:</p> <ol id="MR000032-list-0008"> <li> <p>reminders ‐ <i>intention to be received after a retention time point is reached;</i> </p> </li> <li> <p>prompts ‐ <i>intention to be received before a retention time point is reached;</i> </p> </li> <li> <p>monetary incentives and rewards‐ <i>includes both incentives (i.e. not conditional on behaviour) and rewards (i.e. is conditional on behaviour);</i> </p> </li> <li> <p>non‐monetary incentives;</p> </li> <li> <p>maintaining participant engagement;</p> </li> <li> <p>behavioural intervention.</p> </li> </ol> </li> <li> <p>Sites and site staff (Category C), interventions include:</p> <ol id="MR000032-list-0009"> <li> <p>prompt;</p> </li> <li> <p>monitoring visits.</p> </li> </ol> </li> <li> <p>Central Study Management (Category D), interventions include:</p> <ol id="MR000032-list-0010"> <li> <p>patient public involvement.</p> </li> </ol> </li> <li> <p>Study design (Category E), interventions include:</p> <ol id="MR000032-list-0011"> <li> <p>impact of recruitment;</p> </li> <li> <p>blinding and treatment preference.</p> </li> </ol> </li> </ol> </p> <p>We present the results as RD, pooled using a random‐effects model for all meta‐analyses with more than one included study,and with associated CIs where sufficient data were available. If heterogeneity was detected and could not be explained by subgroup or sensitivity analyses, we did not pool results. </p> <p>For factorial trials, the data for different categories of interventions were included as separate trial comparisons. For multiple retention trials conducted within the same host trial that were not designed to allow for interaction effects between interventions (i.e. did not stratify at randomisation or account for interaction effects in analysis), we pre‐specified the requirement for interventions to be delivered at least six months apart in order to minimise the potential for any intervention interaction effects. In order to minimise interaction effects, we chose not to include data in the meta‐analyses from trials that had evaluated interventions within six months of each other that had not accounted for the interaction effects in the analysis. This resulted in three studies and data from a further four studies (with multiple evaluations) being omitted from our analyses. </p> </section> <section id="MR000032-sec-0033"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to explore the following factors in subgroup analyses assuming enough studies were identified within each comparison. </p> <p> <ul id="MR000032-list-0012"> <li> <p>Type of design used to evaluate the retention strategy (randomised versus quasi‐randomised)</p> </li> <li> <p>Setting of the host trial (e.g. primary versus secondary care, healthcare setting versus non‐healthcare setting) </p> </li> <li> <p>Disease area of the host trial (e.g. oncology versus ante‐natal)</p> </li> <li> <p>Duration of follow‐up (e.g. short versus long term)</p> </li> <li> <p>Value of monetary incentive (e.g. £5 versus £10 etc)</p> </li> </ul> </p> </section> <section id="MR000032-sec-0034"> <h4 class="title">Sensitivity analysis</h4> <p>To assess the robustness of the results, we planned sensitivity analyses that excluded quasi‐randomised retention trials. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="MR000032-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="MR000032-sec-0035"></div> <section id="MR000032-sec-0036"> <h3 class="title">Description of studies</h3> <p>The studies are described in the <a href="./references#MR000032-sec-0058" title="">Characteristics of included studies</a>, <a href="./references#MR000032-sec-0060" title="">Characteristics of studies awaiting classification</a>, <a href="./references#MR000032-sec-0061" title="">Characteristics of ongoing studies</a>, and <a href="./references#MR000032-sec-0059" title="">Characteristics of excluded studies</a> tables. We identified 18,756 abstracts, titles and other records and sought the full text for 150 records to confirm eligibility. In total, 70 papers (reporting data from 81 retention trials) were considered eligible for inclusion (<a href="#MR000032-fig-0001">Figure 1</a>). The studies were conducted in eight countries with two multi‐national studies. The majority of studies (n = 53) were conducted in the UK followed by the USA (n = 10) (<a href="#MR000032-tbl-0017">Table 1</a>). Of these 70 papers, 68 evaluated interventions targeting trial participants and two evaluated interventions targeting individuals involved in trial retention. A total of 101,689 participants were included across the retention trials, which included all participants originally randomised to the retention trial. Included retention trials were conducted in a broad spectrum of clinical conditions across a range of different settings including primary care, secondary care, and community settings. However, similar to the previous version of this review (<a href="./references#MR000032-bbs2-0215" title="BruetonVC , TierneyJ , StenningS , HardingS , MeredithS , NazarethI , et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: MR000032. [DOI: 10.1002/14651858.MR000032.pub2]">Brueton 2013</a>), the included studies were predominantly composed of studies evaluating interventions to improve questionnaire return (n = 70) rather than clinic attendance (n = 2). </p> <div class="figure" id="MR000032-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="1 Included studies flow diagram." data-id="MR000032-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>1 Included studies flow diagram.</p> </div> </div> </div> <div class="table" id="MR000032-tbl-0017"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Countries where the included studies took place</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Country</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norway</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Multinational</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (one involving UK and Ireland and one involving the USA and Canada).</p> </td> </tr> </tbody> </table> </div> <p>The majority of the included trials (42 host trials) included a single retention trial. Some of the included studies reported multiple retention trials (i.e. tested more than one intervention) within one publication (non‐factorial) such as <a href="./references#MR000032-bbs2-0019" title="DinglasVD , HuangM , SepulvedaKA , PinedoM , HopkinsRO , ColantuoniE , et al. Personalized contact strategies and predictors of time to survey completion: analysis of two sequential randomized trials. BMC Medical Research Methodology2015;15:5. [DOI: 10.1186/1471-2288-15-5]">Dinglas 2015</a> (two retention trials), <a href="./references#MR000032-bbs2-0023" title="EdwardsL , SalisburyC , HorspoolK , FosterA , GarnerK , MontgomeryAA . Increasing follow-up questionnaire response rates in a randomized controlled trial of telehealth for depression: three embedded controlled studies. Trials2016;17(1):107. [DOI: 10.1186/s13063-016-1234-3]">Edwards 2016</a> (three retention trials), <a href="./references#MR000032-bbs2-0028" title="GoulaoB , DuncanA , FloateR , ClarksonJ , RamsayC . Three behavior change theory-informed randomized studies within a trial to improve response rates to trial postal questionnaires. Journal of Clinical Epidemiology2020;122:35-41. [DOI: 10.1016/j.jclinepi.2020.01.018]">Goulao 2020</a> (four retention trials), and <a href="./references#MR000032-bbs2-0036" title="KedingA , BrabynS , MacPhersonH , RichmondSJ , TorgersonDJ . Text message reminders to improve questionnaire response rates. Journal of Clinical Epidemiology2016;79:90-5. [DOI: 10.1016/j.jclinepi.2016.05.011]">Keding 2016</a> (three retention trials). Other retention trials were reported separately but embedded within the same host trial. These included trials by <a href="./references#MR000032-bbs2-0004" title="AvenellA , GrantAM , McGeeM , McPhersonG , CampbellMK , McGeeMA , et al. The effects of an open design on trial participant recruitment, compliance and retention - a randomized controlled trial comparison with a blinded, placebo-controlled design. Clinical Trials2004;1(6):490-8. [DOI: 10.1191/1740774504cn053oa]">Avenell 2004</a> and <a href="./references#MR000032-bbs2-0043" title="MacLennanG , McDonaldA , McPhersonG , TreweekS , AvenellA , RECORD Trial Group. Advance telephone calls ahead of reminder questionnaires increase response rate in non-responders compared to questionnaire reminders only: The RECORD phone trial. Trials2014;15:13. [DOI: 10.1186/1745-6215-15-13]">MacLennan 2014</a> in the RECORD fracture prevention trial; <a href="./references#MR000032-bbs2-0014" title="CockayneS , FairhurstC , AdamsonJ , HewittC , HullR , HicksK , et al. An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trial. Trials2017;18(1):144. [DOI: 10.1186/s13063-017-1797-7]">Cockayne 2017</a> and <a href="./references#MR000032-bbs2-0059" title="RodgersS , SbizzeraI , CockayneS , FairhurstC , LambSE , VernonW , et al. A study update newsletter or Post-it® note did not increase postal questionnaire response rates in a falls prevention trial: an embedded randomised factorial trial. F1000Research2019;7:1083. [DOI: 10.12688/f1000research.14591.2]">Rodgers 2019</a> in the REFORM trial; <a href="./references#MR000032-bbs2-0039" title="KhadjesariZ , MurrayE , KalaitzakiE , WhiteI , Mc CambridgeJ , ThompsonS . Impact and costs of incentives to reduce attrition in online trials: two randomised controlled trials. Journal of Medical Internet Research2011;13(1):e26. [DOI: 10.2196/jmir.1523]">Khadjesari 2011</a> and <a href="./references#MR000032-bbs2-0049" title="McCambridgeJ , KalaitzakiE , WhiteRI , KhadjesariZ , MurrayE , LinkeS . Impact of length or relevance of questionnaires on attrition in online trials: randomized controlled trial. Journal of Medical Internet Research2011;13(4):e96. [DOI: 10.2196/jmir.1733]">McCambridge 2011</a> in the Down your Drink Trial; <a href="./references#MR000032-bbs2-0005" title='BaileyJ . Evaluating the effectiveness of incentives in the "Sexunzipped" trial. Personal communication - email. '>Bailey 2013</a> in a feasibility study for the Sex unzipped website; <a href="./references#MR000032-bbs2-0050" title="McCollEM , EcclesMP , RousseauNS , SteenIN , ParkinDW , GrimshawJM . From the generic to the condition-specific? Instrument order effects in quality of life assessment. Medical Care2003;41(7):777-90. [DOI: 10.1097/00005650-200307000-00002]">McColl 2003 ‐ Trial 1</a> and <a href="./references#MR000032-bbs2-0051" title="McCollEM , EcclesMP , RousseauNS , SteenIN , ParkinDWD , GrimshawJM . From the generic to the condition-specific? Instrument order effects in quality of life assessment. Medical Care2003;41(7):777-90. [DOI: 10.1097/00005650-200307000-00002]">McColl 2003 ‐ Trial 2</a> in the COGENT trial; <a href="./references#MR000032-bbs2-0052" title="MitchellN , HewittCE , TorgersonDJ , SCOOP Trial Group. A controlled trial of envelope colour for increasing response rates in older women. Aging Clinical and Experimental Research2011;23(3):236-40. [DOI: 10.1007/bf03337749]">Mitchell 2011</a>, <a href="./references#MR000032-bbs2-0053" title="MitchellN , HewittCE , LenaghanE , PlattE , ShepstoneL , TorgersonDJ , SCOOP study team. Prior notification of trial participants by newsletter increased response rates: a randomized controlled trial. Journal of Clinical Epidemiology2012;65(12):1348-52. [DOI: 10.1016/j.jclinepi.2012.05.008]">Mitchell 2012</a>, and <a href="./references#MR000032-bbs2-0008" title="BellK , ClarkL , FairhurstC , MitchellN , LenaghanE , BlacklockJ , et al. Enclosing a pen reduced time to response to questionnaire mailings. Journal of Clinical Epidemiology2016;74:144-50. [DOI: 10.1016/j.jclinepi.2015.]">Bell 2016</a> in the SCOOP trial; <a href="./references#MR000032-bbs2-0012" title="CochraneA , WelchC , FairhurstC , CockayneS , TorgersonDJ , OTIS Study Group. An evaluation of a personalised text message reminder compared to a standard text message on postal questionnaire response rates: an embedded randomised controlled trial. F1000Research2020;9:154. [DOI: 10.12688/f1000research.22361.1]">Cochrane 2020</a>, <a href="./references#MR000032-bbs2-0035" title="JamesS , ParkerA , CockayneS , RodgersS , FairhurstC , TorgersonD , et al. Including a pen and/or cover letter, containing social incentive text, had no effect on questionnaire response rate: a factorial randomised controlled Study within a Trial. F1000Research2020;9:623. [DOI: 10.12688/f1000research.23767.1]">James 2020</a> and <a href="./references#MR000032-bbs2-0071" title="WhitesideK , FlettL , MitchellA , FairhurstC , CockayneS , RodgersS , et al, OTIS Study Group. Using pens as an incentive for trial recruitment of older adults: An embedded randomised controlled trial. F1000Research2019;8:315. [DOI: 10.12688/f1000research.18300.1]">Whiteside 2019</a> in the OTIS trial; and <a href="./references#MR000032-bbs2-0054" title="MitchellAS , CookL , DeanA , FairhurstC , NorthgravesM , TorgersonD , et al. Using pens as an incentive for questionnaire return in an orthopaedic trial: an embedded randomised controlled retention trial. F1000Research2020;9:321. [DOI: 10.12688/f1000research.23018.1]">Mitchell 2020a</a> and <a href="./references#MR000032-bbs2-0055" title="MitchellAS , CookL , DeanA , FairhurstC , NorthgravesM , TogersonD , et al. An embedded randomised controlled retention trial of personalised text messages compared to non-personalised text messages in an orthopaedic setting. F1000Research2020;9:591. ">Mitchell 2020b</a> in the KReBS trial. </p> <p>There was too much variability and not enough depth (i.e. meaningful replication) in the data set to allow us to conduct any of our planned subgroup analyses. </p> <p>Two studies (<a href="./references#MR000032-bbs2-0163" title="LetleyL , GarrattA . Questionnaire length and internal reliability: a randomised study. In: Society for Social Medicine 43rd Annual Scientific Meeting; 2000 6-8 Sept; Norwich. 2000. ">Letley 2000</a> and <a href="./references#MR000032-bbs2-0164" title="SutherlandHJ , BeatonM , MazerR , KriukovV , BoydNF . A randomized trial of the total design method for the postal follow-up of women in a cancer prevention trial. European Journal of Cancer Prevention1996;5(3):165-8. [DOI: 10.1097/00008469-199606000-00004] [PMID: 8818605]">Sutherland 1996</a>) are awaiting classification. We were unable to include them due to a lack of information on the number of participants randomised to each arm (<a href="./references#MR000032-bbs2-0163" title="LetleyL , GarrattA . Questionnaire length and internal reliability: a randomised study. In: Society for Social Medicine 43rd Annual Scientific Meeting; 2000 6-8 Sept; Norwich. 2000. ">Letley 2000</a>), or whether the feasibility they report ahead of the full trial was also randomised (<a href="./references#MR000032-bbs2-0164" title="SutherlandHJ , BeatonM , MazerR , KriukovV , BoydNF . A randomized trial of the total design method for the postal follow-up of women in a cancer prevention trial. European Journal of Cancer Prevention1996;5(3):165-8. [DOI: 10.1097/00008469-199606000-00004] [PMID: 8818605]">Sutherland 1996</a>). </p> </section> <section id="MR000032-sec-0037"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#MR000032-sec-0058" title="">Characteristics of included studies</a>, <a href="#MR000032-fig-0002">Figure 2</a> and <a href="#MR000032-fig-0003">Figure 3</a>. Authors of trials included in the meta‐analysis reported their studies as either randomised (n = 70) or quasi‐randomised (n = 2). One study included both randomised and quasi‐randomised retention trials (<a href="./references#MR000032-bbs2-0023" title="EdwardsL , SalisburyC , HorspoolK , FosterA , GarnerK , MontgomeryAA . Increasing follow-up questionnaire response rates in a randomized controlled trial of telehealth for depression: three embedded controlled studies. Trials2016;17(1):107. [DOI: 10.1186/s13063-016-1234-3]">Edwards 2016</a>). The overall risk of bias was considered low for 14 studies, unclear for 50 studies and high for eight studies. </p> <div class="figure" id="MR000032-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="MR000032-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="MR000032-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="MR000032-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> </section> <section id="MR000032-sec-0038"> <h3 class="title" id="MR000032-sec-0038">Effect of methods</h3> <p>We only report comparisons including studies (single studies or overall comparisons) at low or unclear risk of bias in these results. The list of all 52 comparisons, including those of high risk of bias, is included in <a href="#MR000032-tbl-0018">Table 2</a>, <a href="#MR000032-tbl-0019">Table 3</a>, <a href="#MR000032-tbl-0020">Table 4</a>, <a href="#MR000032-tbl-0021">Table 5</a> and <a href="#MR000032-tbl-0022">Table 6</a>. The categorisation of interventions into categories, based on the ORRCA retention domains, was not always clear and was largely informed by the original study authors' intention as described or implied within their report. </p> <div class="table" id="MR000032-tbl-0018"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Data collection (Category A)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sub‐domains</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>1A. Questionnaire design: Questionnaire length</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#MR000032-bbs2-0021" title="DormanP , SlatteryJ , FarrellB , DennisMS , SandercockPA . A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial. BMJ1997;315(7106):461. ">Dorman 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New questionnaire</p> <p>(Shorter version)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#MR000032-bbs2-0022" title="EdwardsP , RobertsI , SandercockP , FrostC . Follow-up by mail in clinical trials: does questionnaire length matter?Controlled Clinical Trials2004;25(1):31-52. [DOI: 10.1016/j.cct.2003.08.013]">Edwards 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New questionnaire</p> <p>(Shorter version)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subar 2001</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New questionnaire</p> <p>(Shorter version)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>2A. Questionnaire design: Addition of a diary to usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Griffin 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diaries follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal questionnaires follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marques2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resource use log to prospectively record their use of health services</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No resource use log</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>3A. Questionnaire design: Question order, condition first vs generic first question</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>McColl 2003</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Condition‐specific measures of quality of life preceded generic instruments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Questionnaires in a reverse order</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>4A. Data collection frequency and timing: Timing of questionnaire delivery</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renfroe 2002</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of postal questionnaire, cover letter signatory, express</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Regular mail, non‐monetary incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>5A. Data Collection Location and Method: Postal follow‐up vs clinic follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greig 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>6A. Data Collection Location and Method: Telephone follow‐up vs postal questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Couper 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Postal trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up with an incentive</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Telephone trail)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up with an incentive</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>7A. Data Collection Location and Method: First class vs second class outward mailing</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sharp 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>First‐class post</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Second class</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>8A. Data Collection Location and Method: Return postage</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sharp 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Preaddressed second class stamped envelope</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Business reply envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenton 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'high priority' stamp to the mailing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Business format mailing</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dinglas 2015 (Mail trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised postal follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Generic postal follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>9A. Data Collection Location and Method: Use of self‐sampling kits</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranberg 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a modified second reminder, a leaflet, and a self‐sampling kit.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>received the same material as those in the directly mailed group but received no kit</p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0019"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Participants (Category B)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sub‐domains</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>10B. Reminders: electronic reminder vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ashby 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Additional electronic reminder in follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (Email reminder)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Email reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal email reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (SMS text pre‐notification)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prenotification reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>11B. Reminders: action oriented electronic reminder vs standard electronic reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (photo trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The personalised photo on the letter</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (pre‐call trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>12B. Reminders: personalised reminder vs non‐personalised reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nakash2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calendar</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message the day before the email with the link to the questionnaire. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No SMS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>13B. Reminders: telephone reminder vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severi 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone call reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>14B. Reminders: telephone reminder vs postal reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tai 1997</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>15B. Prompts: electronic prompt vs no prompt</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message and a further £10 high‐street shopping voucher sent by post before the 24 months visit. </p> <p>Intervention group 2 received a further £10 high‐street shopping voucher given at the visit. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clark 2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received an SMS or e‐mail to return a study questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no electronic prompt to returns a study questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Keding 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Text message prompt</p> <p>Prompt</p> <p>Reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> <p>Reminder</p> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Man 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electronic reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (Email reminder)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Email reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal email reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (SMS text pre‐notification)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prenotification reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>16B. Prompts: telephone prompt vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (Email trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of an email as prompt</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual Follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MacLennan 2014</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a telephone call from the trial office ahead of the reminder questionnaire in addition to the usual reminder schedule </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received the usual reminder schedule only</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>17B. Prompts: Prenotification card vs no card</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treweek 2020a</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐notification card sent around 1 month before</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pre‐notification card</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>18B. Prompts: sticker vs no sticker</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a logo sticker on questionnaire envelopes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no sticker</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>19B. Prompts: personalised prompt vs no prompt</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐personalised reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised text message</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No personalised text message</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nakash 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calendar</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>20B. Monetary incentives: addition of monetary incentives vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bauer 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions group 1 received an incentive of US$10</p> <p>Interventions group 2 received an incentive of US$2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gates 2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>£5 gift voucher</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no gift voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenyon 2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Monetary incentive (£5 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>21B. Monetary incentives: addition of monetary incentives to all trial arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bauer 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions group 1 received an incentive of US$10</p> <p>Interventions group 2 received an incentive of US$2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message and a further £10 high‐street shopping voucher sent by post before the 24‐month visit. </p> <p>Intervention group 2 received a further £10 high‐street shopping voucher given at the visit. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>22B. Monetary incentives: addition of monetary incentives vs addition of monetary reward </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message and a further £10 high‐street shopping voucher sent by post before the 24 months visit. </p> <p>Intervention group 2 received a further £10 high‐street shopping voucher given at the visit. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cook 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>£20 gift voucher given to study at the end of the recruitment visit</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A conditional offer of monetary incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dorling 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received the first paper letter to parents included a promise of an incentive (£15 gift voucher redeemable at some shops) after receipt of a completed form. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received the first paper letter to parents would enclose the incentive (£15 gift voucher redeemable at high‐street shops) before the receipt of a completed form </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Young 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of monetary incentive (£5 multistore voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of incentive (i.e. Conditional vs unconditional £5 multistore voucher)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>23B. Monetary incentives: addition of monetary reward vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Clinic trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic visit with an incentive (£2 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic visit without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Postal trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up with incentive (£2 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Telephone trail)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up with incentive (£2 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Watson 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Intervention group 1</i> received unconditional (£5 gift voucher) at 12 but not 24 months. </p> <p><i>Intervention group 2</i> received unconditional (£5 gift voucher) at 12 and 24 months. </p> <p><i>Intervention group 3</i> received unconditional (£5 gift voucher) at 24 but not 12 months. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Arundel 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of conditional monetary incentive (£10 cash reliant on providing in addition to the £10 gift voucher routinely provided) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up (£10 gift voucher routinely provided)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>24B. Monetary incentives: addition of monetary rewards to all trial arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hardy 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of conditional monetary incentive (£10 gift voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Later offer of conditional monetary incentive (£10 gift voucher)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>25B. Monetary incentives: addition of monetary incentives vs lottery</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenton 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Monetary incentive (CAN$2 coin mailed with the questionnaire or draw for a CAN$50 gift certificate upon questionnaire receipt) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lottery</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>26B. Monetary incentives: lottery vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>No incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>27B. Monetary incentives: addition of lottery to both trial arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Henderson 2010</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of winning voucher (winning 1 of 25 £20 shopping vouchers or winning one £500 shopping voucher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>28B. Non‐monetary incentives: addition of pen vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bell 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a pen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cunningham‐Burley 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Branded pen with their questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>James 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pen with trial invitation pack</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2020b</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a pen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sharp 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>29B. Non‐monetary incentives: addition of societal benefit message vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severi 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fridge magnet and benefit to society message</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>30B. Non‐monetary incentives: certificate of appreciation vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renfroe 2002</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of postal questionnaire, cover letter signatory, express mail</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Regular mail and non‐monetary incentive.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>31B. Maintaining participant engagement: newsletter vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a tested a theoretically informed newsletter sent before the questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no newsletter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MARMOTH trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newsletter one month before the 24‐month paper follow‐up questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No newsletter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a white envelope</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a brown envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rodgers 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newsletter + handwritten posit it notes</p> <p>Newsletter + printed posit it notes</p> <p>Newsletter only</p> <p>Handwritten posit it notes only</p> <p>Printed posit it note only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>32B. Maintaining participant engagement: offer of receiving trial results vs usual follow‐up </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cockayne 2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Offered the result of the trial in a questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No offer of knowing the results</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>33B. Maintaining participant engagement: cover letter including a social incentive vs standard cover letter </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>James 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Intervention group 1</i> received a branded pen and a standard cover letter. </p> <p><i>Intervention group 2</i> received a branded pen and a social incentive cover letter. </p> <p><i>Intervention group 3</i> received no pen and a social incentive cover letter. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Control group</i> received no pen, standard cover letter. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>34B. Maintaining participant engagement: personalised cover letter vs usual cover letter </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (Email trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of an email as prompt</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (photo trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised photo on the letter</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (pre‐call trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>35B. Maintaining participant engagement: varying signatory on cover letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renfroe 2002</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of postal questionnaire, cover letter signatory, express mail</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Regular mail and non‐monetary incentive.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>36B. Maintaining participant engagement: addition of a deadline vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gatellari 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cover letter advising return within 1‐week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard cover letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>37B. Maintaining participant engagement: addition of an estimate of time to complete vs no addition </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marson 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cover letter though post with the questionnaire that included an estimate of the length of time that it may take to complete </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard cover letter with no indication of length of time required</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>38B. Maintaining participant engagement: brown vs white envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a white envelope</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a brown envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>39B. Maintaining participant engagement: post‐it notes vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lewis 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a post‐it note</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rodgers 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newsletter + handwritten posit it notes</p> <p>Newsletter + printed posit it notes</p> <p>Newsletter only</p> <p>Handwritten posit it notes only</p> <p>Printed posit it note only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tilbrook 2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a post‐it note</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>40B. Maintaining participant engagement: inclusion of trial newspaper article vs usual follow‐up </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvesen 1992</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newspaper article</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>41B. Maintaining participant engagement: frequency of telephone contact</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Glassman 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received telephone calls at baseline, six months, and at annual visits after that (annual contact) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a call at baseline only (baseline contact)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>42B. Maintaining participant engagement: request for collateral (concomitant)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cunningham 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Intervention group</i> <i>1</i> were asked to provide a collateral. </p> <p><i>Intervention group</i> <i>2</i> asked to provide collateral and told that there was a 50% chance that the collateral would be contacted. </p> <p>All those respondents asked for collateral were told that the collateral would receive a CAN$20 payment for a brief telephone interview. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not asked to provide a collateral</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>43B. Behavioural interventions: theory informed cover letter vs usual cover letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AMBER trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a tested a theoretically informed letter sent with the questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a standard letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Theory informed letter to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020 (replication)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Theory informed letter to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OPAL trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a tested a theoretically informed letter sent with the questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a standard letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>44B. Behavioural interventions: motivational interviewing vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bean 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Theory informed to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0020"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Sites and site staff (Category C)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sub‐domains</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>45C. Prompts: site prompts for upcoming assessments vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Land 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a monthly reminder to sites listing participants who were due to have a measure in the next three months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>46C. Monitoring visits: on‐site monitoring vs no visit</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lienard 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Centres received a systematic on‐site visit (Visited group)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not receive a systematic on‐site visit (Non‐visited group)</p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0021"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Central Study Management (Category D)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sub‐domains</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>47D. Patient Public Involvement: peer‐led follow‐up strategy vs usual follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fouad 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Peer‐led strategy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual follow‐up</p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000032-tbl-0022"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Study design (Category E)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sub‐domains</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>48E. Impact of recruitment: video‐enhanced patient information vs standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brubaker 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change to information provided at recruitment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>49E. Impact of recruitment: optimised information vs standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cockayne 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Optimised patient information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard patient information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Guarino 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change to information provided at recruitment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>50E. Impact of recruitment: addition of optimised information to both arms</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cockayne 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Optimised patient information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard patient information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>51E. Impact of recruitment: pen vs no pen</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Whiteside 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐monetary incentive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual practice (at recruitment)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>52E. Blinding and treatment preference: open vs blind trial design</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Avenell 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open design</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blinded design</p> </td> </tr> </tbody> </table> </div> <p>'Summary of findings' tables were produced for all interventions where more than one study evaluated effectiveness. This provided 16 in total: <a href="./full#MR000032-tbl-0001">summary of findings Table 1</a>, <a href="./full#MR000032-tbl-0002">summary of findings Table 2</a>, <a href="./full#MR000032-tbl-0003">summary of findings Table 3</a>, <a href="./full#MR000032-tbl-0004">summary of findings Table 4</a>, <a href="./full#MR000032-tbl-0005">summary of findings Table 5</a>, <a href="./full#MR000032-tbl-0006">summary of findings Table 6</a>, <a href="./full#MR000032-tbl-0007">summary of findings Table 7</a>, <a href="./full#MR000032-tbl-0008">summary of findings Table 8</a>, <a href="./full#MR000032-tbl-0009">summary of findings Table 9</a>, <a href="./full#MR000032-tbl-0010">summary of findings Table 10</a>, <a href="./full#MR000032-tbl-0011">summary of findings Table 11</a>, <a href="./full#MR000032-tbl-0012">summary of findings Table 12</a>, <a href="./full#MR000032-tbl-0013">summary of findings Table 13</a>, <a href="./full#MR000032-tbl-0014">summary of findings Table 14</a>, <a href="./full#MR000032-tbl-0015">summary of findings Table 15</a> and <a href="./full#MR000032-tbl-0016">summary of findings Table 16</a>. </p> <p><b>Data Collection ‐ Category A (</b><a href="#MR000032-tbl-0018">Table 2</a>) </p> <p>Fourteen studies across nine comparisons focused on aspects of data collection to improve retention. The results from studies, or comparisons, that were low or unclear risk of bias are presented below and included 35,215 participants. We have not presented data for comparisons where only a single high risk of bias study was available for any of the compairsons across categories. </p> <p><i>Questionnaire design</i> </p> <p> <ol id="MR000032-list-0013"> <li> <p>The evidence is very uncertain about the effect of a short questionnaire compared to the usual trial questionnaire: risk difference (RD) = 0% (95% confidence interval (CI) ‐8% to 8%); GRADE: very low; (<a href="./references#MR000032-fig-0004" title="">Analysis 1.1</a>, <a href="./full#MR000032-tbl-0001">summary of findings Table 1</a>). This result is based on three studies, n = 3252: <a href="./references#MR000032-bbs2-0022" title="EdwardsP , RobertsI , SandercockP , FrostC . Follow-up by mail in clinical trials: does questionnaire length matter?Controlled Clinical Trials2004;25(1):31-52. [DOI: 10.1016/j.cct.2003.08.013]">Edwards 2004</a> (head injury), <a href="./references#MR000032-bbs2-0065" title="SubarAF , ZieglerRG , ThompsonFE , JohnsonCC , WeissfeldJL , RedingD , et al. Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. American Journal of Epidemiology2001;153(4):404-9. [DOI: 10.1093/aje/153.4.404]">Subar 2001</a> (cancer screening) and <a href="./references#MR000032-bbs2-0021" title="DormanP , SlatteryJ , FarrellB , DennisMS , SandercockPA . A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial. BMJ1997;315(7106):461. ">Dorman 1997</a> (stroke). </p> </li> <li> <p>Addition of a diary to usual follow‐up compared to usual follow‐up alone probably reduces retention slightly: RD = ‐3% (95% CI ‐4% to ‐2%); GRADE: moderate; (<a href="./references#MR000032-fig-0005" title="">Analysis 2.1</a>, <a href="./full#MR000032-tbl-0002">summary of findings Table 2</a>). This result is based on two studies, n =9906: <a href="./references#MR000032-bbs2-0031" title="GriffinJ , LallR , BruceJ , WithersE , FinneganS , LambSE , PreFIT Study Group. Comparison of alternative falls data collection methods in the Prevention of Falls Injury Trial (PreFIT). Journal of Clinical Epidemiology2019;106:32-40. [DOI: 10.1016/j.jclinepi.2018.09.006]">Griffin 2019</a> (falls prevention) and <a href="./references#MR000032-bbs2-0046" title="MarquesE , JohnsonEC , Gooberman-HillR , BlomAW , NobleS . Using resource use logs to reduce the amount of missing data in economic evaluations alongside trials. Value Health2013;16(1):195-201. [DOI: 10.1016/j.jval.2012.09.008]">Marques 2013</a> (hip/knee replacement). </p> </li> </ol> </p> <p><i>Data collection frequency/timing</i> </p> <p> <ol id="MR000032-list-0014"> <li> <p>The evidence is very uncertain about the effect of a final questionnaire sent at trial close out compared to last study visit: <a href="./references#MR000032-bbs2-0058" title="RenfroeEG , HeywoodG , ForemanL , SchronE , PowellJ , BaesslerC , et al. The end-of-study patient survey: methods influencing response rate in the AVID trial. Controlled Clinical Trials2002;23(5):521-33. RenfroeEG , PowellJ , OlarteA , MorrisM , HallstromA . Method of administering patient surveys affects response rate. Controlled Clinical Trials1999;20:s62. [DOI: 10.1016/s0197-2456(02)00225-8]">Renfroe 2002</a> (arrhythmia): RD = 7% (95% CI ‐1% to 14%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 479; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0007" title="">Analysis 4.1</a>). </p> </li> </ol> </p> <p><i>Data collection location and method</i> </p> <p> <ol id="MR000032-list-0015"> <li> <p>The evidence is very uncertain about the effect of postal follow‐up compared to clinic follow‐up on retention: <a href="./references#MR000032-bbs2-0030" title="GreigA , GardinerMD , SierakowskiA , ZweifelCJ , PinderRM , FurnissD , et al. Randomized feasibility trial of replacing or discarding the nail plate after nail-bed repair in children. British Journal of Surgery2017;104(12):1634-9. [DOI: 10.1002/bjs.10673]">Greig 2017</a> (nail‐bed injury): RD = 16% (95% CI ‐8% to 40%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 60; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0008" title="">Analysis 5.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect of telephone follow‐up compared to postal follow‐up on retention: RD = 2% (95% CI ‐4% to 9%); GRADE: very low; (<a href="./references#MR000032-fig-0009" title="">Analysis 6.1</a>, <a href="./full#MR000032-tbl-0003">summary of findings Table 3</a>). This result is based on two studies, n = 1006: <a href="./references#MR000032-bbs2-0016" title="CouperPM , PeytchevA , StrecherJV , RothertK , AndersonJ . Following up non respondents to an online weight management intervention: randomized trial comparing mail versus telephone. Journal of Medical Internet Research2007;9(2):e16. [DOI: 10.2196/jmir.9.2.e16]">Couper 2007</a> (obesity) and <a href="./references#MR000032-bbs2-0047" title="MarshP , KendrickD . Using a diary to record near misses and minor injuries?which method of administration is best?Injury Prevention1999;5:305-9. ">Marsh 1999</a> (injury prevention). </p> </li> <li> <p>First class postage for outward mail compared to second class postage may increase retention slightly: <a href="./references#MR000032-bbs2-0063" title="SharpL , CochranC , CottonSC , GrayNM , GallagherME , TOMBOLA group. Enclosing a pen with a postal questionnaire can significantly increase the response rate. Journal of Clinical Epidemiology2006;59(7):747-54. [DOI: 10.1016/j.jclinepi.2005.10.014]">Sharp 2006</a> (cervical screening): RD = 2% (95% CI ‐4% to 8%); GRADE low (‐1 level: study limitations– unclear risk of bias; ‐1 level: imprecision‐single study, n = 930) (<a href="./references#MR000032-fig-0011" title="">Analysis 7.1</a>) </p> </li> <li> <p>Various strategies compared to usual practice for return postage, such as free post versus second class stamp; high priority mail stamp versus usual postage; and personal form may increase retention slightly: RD = 4% (95% CI ‐0% to 9%); GRADE: low; (<a href="./references#MR000032-fig-0012" title="">Analysis 8.1</a>, <a href="./full#MR000032-tbl-0004">summary of findings Table 4</a>). This result is based on three studies, n = 1543: <a href="./references#MR000032-bbs2-0063" title="SharpL , CochranC , CottonSC , GrayNM , GallagherME , TOMBOLA group. Enclosing a pen with a postal questionnaire can significantly increase the response rate. Journal of Clinical Epidemiology2006;59(7):747-54. [DOI: 10.1016/j.jclinepi.2005.10.014]">Sharp 2006</a> (cervical screening), <a href="./references#MR000032-bbs2-0021" title="DormanP , SlatteryJ , FarrellB , DennisMS , SandercockPA . A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial. BMJ1997;315(7106):461. ">Dorman 1997</a> (stroke) and <a href="./references#MR000032-bbs2-0019" title="DinglasVD , HuangM , SepulvedaKA , PinedoM , HopkinsRO , ColantuoniE , et al. Personalized contact strategies and predictors of time to survey completion: analysis of two sequential randomized trials. BMC Medical Research Methodology2015;15:5. [DOI: 10.1186/1471-2288-15-5]">Dinglas 2015</a> (acute lung injury) </p> </li> <li> <p>The use of self‐sampling kits (directly mailed or an invitation to order) probably increases retention: <a href="./references#MR000032-bbs2-0068" title="TranbergM , BechBH , BlaakærJ , JensenJS , SvanholmH , AndersenB . Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial. BMC Cancer2018;18(1):273. [DOI: 10.1186/s12885-018-4165-4]">Tranberg 2018</a> (cervical screening) split across several subgroups: RD = 9% (95% CI 4% to 13%); GRADE moderate (‐1 level: imprecision‐single study, n = 19,582) (<a href="./references#MR000032-fig-0013" title="">Analysis 9.1</a>). </p> </li> </ol> </p> <p><b>Participants ‐ Category B (</b><a href="#MR000032-tbl-0019">Table 3</a>) </p> <p>The domain for interventions focusing on participants contained the largest number of interventions (35 comparisons) and studies (n = 49) and included 57,033 participants are presented below. </p> <p><i>Reminders</i> </p> <p> <ol id="MR000032-list-0016"> <li> <p>Electronic reminders compared to usual follow‐up may result in little or no difference to retention RD = 1% (95% CI ‐4% to 6%); GRADE: low; (<a href="./references#MR000032-fig-0014" title="">Analysis 10.1</a>, <a href="./full#MR000032-tbl-0005">summary of findings Table 5</a>). This result is based on three studies, n = 790: <a href="./references#MR000032-bbs2-0003" title="AshbyR , TurnerG , CrossB , MitchellN , TorgersonD . A randomized trial of electronic reminders showed a reduction in the time to respond to postal questionnaires. Journal of Clinical Epidemiology2011;64:208-12. [DOI: 10.1016/j.jclinepi.2010.01.020]">Ashby 2011</a> (migraine), <a href="./references#MR000032-bbs2-0036" title="KedingA , BrabynS , MacPhersonH , RichmondSJ , TorgersonDJ . Text message reminders to improve questionnaire response rates. Journal of Clinical Epidemiology2016;79:90-5. [DOI: 10.1016/j.jclinepi.2016.05.011]">Keding 2016</a> (depression),and <a href="./references#MR000032-bbs2-0064" title="StarrK , McPhersonG , ForrestM , CottonSC . SMS text pre-notification and delivery of reminder e-mails to increase response rates to postal questionnaires in the SUSPEND trial: a factorial design, randomised controlled trial. Trials2015;16:295. [DOI: 10.1186/s13063-015-0808-9]">Starr 2015</a> (ureteric stones). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of action oriented electronic reminders (e.g. 'ACTION REQUIRED' in email subject line) compared to a standard electronic reminder: <a href="./references#MR000032-bbs2-0023" title="EdwardsL , SalisburyC , HorspoolK , FosterA , GarnerK , MontgomeryAA . Increasing follow-up questionnaire response rates in a randomized controlled trial of telehealth for depression: three embedded controlled studies. Trials2016;17(1):107. [DOI: 10.1186/s13063-016-1234-3]">Edwards 2016</a> (depression with cardiovascular disease): RD = ‐4% (95% CI ‐10% to 3%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 231; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0015" title="">Analysis 11.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of a personalised versus a non‐personalised reminder: <a href="./references#MR000032-bbs2-0056" title="NakashRA . A Study of Response and Non-Response to Postal Questionnaire Follow-up in Clinical Trials: Chapter 6: A Randomised Controlled Trial of a Method of Improving Response to Postal Questionnaire Follow-up in a Clinical Trial [PhD thesis]. Warwick, UK: University of Warwick, Warwick Medical School, 2007. ">Nakash 2007</a> (severe ankle sprains): RD = ‐1% (95% CI ‐11% to 8%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 298; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0016" title="">Analysis 12.1</a>). </p> </li> <li> <p>Telephone reminders compared to usual follow‐up may result in little or no difference to retention: <a href="./references#MR000032-bbs2-0062" title="SeveriE , FreeC , KnightR , RobertsonS , EdwardsP , HoileE . Two controlled trials to increase participant retention in a randomized controlled trial of mobile phone-based smoking cessation support in the United Kingdom. Clinical Trials2011;8(5):654-60. [DOI: 10.1177/1740774511416524]">Severi 2011</a> (smoking cessation): RD = ‐1% (95% CI ‐18% to 15%); GRADE low (‐2 levels: imprecision‐single study, n = 127; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0017" title="">Analysis 13.1</a>). </p> </li> <li> <p>Telephone reminders compared to postal reminders, may result in a large increase in retention: <a href="./references#MR000032-bbs2-0066" title="TaiSS , NazarethI , HainesA , JowettC . A randomized trial of the impact of telephone and recorded delivery reminders on the response rate to research questionnaires. Journal of Public Health Medicine1997;19(2):219-21. [DOI: 10.1093/oxfordjournals.pubmed.a024613]">Tai 1997</a>, (asthma and/or diabetes): RD = ‐19% (95% CI ‐33% to ‐5%); GRADE low (‐1 level: study limitations– unclear risk of bias; ‐1 levels: imprecision‐single study, n = 148) (<a href="./references#MR000032-fig-0018" title="">Analysis 14.1</a>). </p> </li> </ol> </p> <p><i>Prompts</i> </p> <p> <ol id="MR000032-list-0017"> <li> <p>The evidence is very uncertain about the effect on retention of electronic prompts compared to no prompt: RD = 2% (95% CI ‐1% to 6%); GRADE: very low; (<a href="./references#MR000032-fig-0019" title="">Analysis 15.1</a>, <a href="./full#MR000032-tbl-0006">summary of findings Table 6</a>). This result is based on five studies, n = 2897: <a href="./references#MR000032-bbs2-0009" title="BradshawLE , MontgomeryAA , WilliamsHC , ChalmersJR , HainesRH . Two-by-two factorial randomised study within a trial (SWAT) to evaluate strategies for follow-up in a randomised prevention trial. Trials.2020;21(1):529. [DOI: 10.1186/s13063-020-04373-4]">Bradshaw 2020</a> (eczema), <a href="./references#MR000032-bbs2-0011" title="ClarkL , RonaldsonS , DysonL , HewittC , TorgersonD , AdamsonJ . Electronic prompts significantly increase response rates to postal questionnaires: a randomized trial within a randomized trial and meta-analysis. Journal of Clinical Epidemiology2015;68(12):1446-50. [DOI: 10.1016/j.jclinepi.2015.01.016]">Clark 2015</a> (chronic obstructive pulmonary disease), <a href="./references#MR000032-bbs2-0036" title="KedingA , BrabynS , MacPhersonH , RichmondSJ , TorgersonDJ . Text message reminders to improve questionnaire response rates. Journal of Clinical Epidemiology2016;79:90-5. [DOI: 10.1016/j.jclinepi.2016.05.011]">Keding 2016</a> (depression), <a href="./references#MR000032-bbs2-0045" title="ManMS , TilbrookHE , JayakodyS , HewittCE , CoxH , CrossB , et al. Electronic reminders did not improve postal questionnaire response rates or response times: a randomized controlled trial. Journal of Clinical Epidemiology2011;64(1001):e1004. [DOI: 10.1016/j.jclinepi.2010.10.013]">Man 2011</a> (low back pain), and <a href="./references#MR000032-bbs2-0064" title="StarrK , McPhersonG , ForrestM , CottonSC . SMS text pre-notification and delivery of reminder e-mails to increase response rates to postal questionnaires in the SUSPEND trial: a factorial design, randomised controlled trial. Trials2015;16:295. [DOI: 10.1186/s13063-015-0808-9]">Starr 2015</a> (ureteric stones). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of telephone prompts compared to usual follow‐up: RD = 1% (95% CI ‐10% to 12%); GRADE: very low; (<a href="./references#MR000032-fig-0020" title="">Analysis 16.1</a>, <a href="./full#MR000032-tbl-0007">summary of findings Table 7</a>). This result is based on two studies, n = 943: <a href="./references#MR000032-bbs2-0023" title="EdwardsL , SalisburyC , HorspoolK , FosterA , GarnerK , MontgomeryAA . Increasing follow-up questionnaire response rates in a randomized controlled trial of telehealth for depression: three embedded controlled studies. Trials2016;17(1):107. [DOI: 10.1186/s13063-016-1234-3]">Edwards 2016</a> (depression with cardiovascular disease) and <a href="./references#MR000032-bbs2-0043" title="MacLennanG , McDonaldA , McPhersonG , TreweekS , AvenellA , RECORD Trial Group. Advance telephone calls ahead of reminder questionnaires increase response rate in non-responders compared to questionnaire reminders only: The RECORD phone trial. Trials2014;15:13. [DOI: 10.1186/1745-6215-15-13]">MacLennan 2014</a> (fracture prevention). </p> </li> <li> <p>Prenotification cards compared to no card may increase retention slightly: <a href="./references#MR000032-bbs2-0069" title="TreweekS , GallantS , AndersonAS . SWAT 76 evaluation: randomised evaluation of sending pre-notification cards to trial participants before a face-to-face primary outcome measurement. https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,864300,en.pdf. ">Treweek 2020a</a>, n = 558 (breast cancer prevention): RD = 3% (95% CI ‐3% to 10%); GRADE low (‐2 levels: imprecision‐single study; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0021" title="">Analysis 17.1</a>). </p> </li> <li> <p>Use of a sticker on envelope compared to no sticker may result in little or no difference to retention: <a href="./references#MR000032-bbs2-0028" title="GoulaoB , DuncanA , FloateR , ClarksonJ , RamsayC . Three behavior change theory-informed randomized studies within a trial to improve response rates to trial postal questionnaires. Journal of Clinical Epidemiology2020;122:35-41. [DOI: 10.1016/j.jclinepi.2020.01.018]">Goulao 2020</a>. (dentistry): RD = 1% (95% CI ‐7% to 10%); GRADE low (‐2 levels: imprecision‐single study, n = 517; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0022" title="">Analysis 18.1</a>). </p> </li> <li> <p>Personalised prompts compared to usual follow‐up may reduce retention slightly: RD = ‐2% (95% CI ‐9% to 5%); GRADE: low; (<a href="./references#MR000032-fig-0023" title="">Analysis 19.1</a>, <a href="./full#MR000032-tbl-0008">summary of findings Table 8</a>). This result is based on two studies, n = 701: <a href="./references#MR000032-bbs2-0012" title="CochraneA , WelchC , FairhurstC , CockayneS , TorgersonDJ , OTIS Study Group. An evaluation of a personalised text message reminder compared to a standard text message on postal questionnaire response rates: an embedded randomised controlled trial. F1000Research2020;9:154. [DOI: 10.12688/f1000research.22361.1]">Cochrane 2020</a> (falls prevention) with low risk of bias and <a href="./references#MR000032-bbs2-0056" title="NakashRA . A Study of Response and Non-Response to Postal Questionnaire Follow-up in Clinical Trials: Chapter 6: A Randomised Controlled Trial of a Method of Improving Response to Postal Questionnaire Follow-up in a Clinical Trial [PhD thesis]. Warwick, UK: University of Warwick, Warwick Medical School, 2007. ">Nakash 2007</a> (severe ankle sprains) with unclear risk of bias. </p> </li> <li> <p>Electronic prompts compared to electronic reminders seemed to favour electronic reminders may increase retention slightly: <a href="./references#MR000032-bbs2-0061" title="SarathyPP , KottamL , ParkerA , BrealeyS , ColemanE , KedingA , et al. Timing of electronic reminders did not improve trial participant questionnaire response: a randomized trial and meta-analyses. Journal of Clinical Epidemiology2020;6:eprint. ">Sarathy 2020</a> (frozen shoulder): RD 2% (95% CI ‐6% to 9%) GRADE low (‐2 levels: imprecision‐single study, n = 269; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0024" title="">Analysis 20.1</a>) </p> </li> </ol> </p> <p><i>Monetary incentives and rewards</i> </p> <p> <ol id="MR000032-list-0018"> <li> <p>Monetary incentives compared to no incentive may increase retention: RD = 7% (95% CI 4% to 11%); GRADE: low; (<a href="./references#MR000032-fig-0025" title="">Analysis 21.1</a>, <a href="./full#MR000032-tbl-0009">summary of findings Table 9</a>). This result is based on three studies, n = 3166: <a href="./references#MR000032-bbs2-0006" title="BauerJE , RezaishirazH , HeadK , CowellJ , BeplerG , AikenM , et al. Obtaining DNA from a geographically dispersed cohort of current and former smokers: use of mail-based mouthwash collection and monetary incentives. Nicotine and Tobacco Research2004;6(3):439-46. [DOI: 10.1080/14622200410001696583]">Bauer 2004</a> (smoking cessation), <a href="./references#MR000032-bbs2-0025" title="GatesS , WilliamsM , WithersE , WilliamsonE , Mt-IsaS , LambS . Does a monetary incentive improve the response to a postal questionnaire in a randomised controlled trial? The MINT incentive study. Trials2009;10(1):44. [DOI: 10.1186/1745-6215-10-44]">Gates 2009</a> (acute whiplash) both with high risk of bias, and <a href="./references#MR000032-bbs2-0038" title="KenyonS , PikeK , JonesD , TaylorD , SaltA , MarlowN , et al. The effect of a monetary incentive on return of a postal health and development questionnaire: a randomised trial. BMC Health Services Research2005;5(1):55. [DOI: 10.1186/1472-6963-5-55]">Kenyon 2005</a> (neonatal) with unclear risk of bias. A sensitivity analysis was conducted that excluded the quasi‐randomised trial (<a href="./references#MR000032-bbs2-0025" title="GatesS , WilliamsM , WithersE , WilliamsonE , Mt-IsaS , LambS . Does a monetary incentive improve the response to a postal questionnaire in a randomised controlled trial? The MINT incentive study. Trials2009;10(1):44. [DOI: 10.1186/1745-6215-10-44]">Gates 2009</a>). This showed a similar effect in that it may increase retention: RD 9%, 95% CI 2% to 16%; but the certainty in the certainty in the evidence is GRADE low (<a href="./references#MR000032-fig-0026" title="">Analysis 21.2</a>) </p> </li> <li> <p>Addition of monetary incentives to all trial arms may favour the higher value incentive to increase retention: <a href="./references#MR000032-bbs2-0006" title="BauerJE , RezaishirazH , HeadK , CowellJ , BeplerG , AikenM , et al. Obtaining DNA from a geographically dispersed cohort of current and former smokers: use of mail-based mouthwash collection and monetary incentives. Nicotine and Tobacco Research2004;6(3):439-46. [DOI: 10.1080/14622200410001696583]">Bauer 2004</a> (smoking cessation): RD = 10% (95% CI 3% to 23%); GRADE: low (‐2 levels: imprecision‐single study, n = 200 ; wide CI crossing RD = 0) ( <a href="./references#MR000032-fig-0025" title="">Analysis 21.1</a>) </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of the addition of a monetary incentive (unconditional) versus addition of a monetary reward (conditional): RD = ‐0% (95% CI ‐7% to 6%); GRADE: very low; (<a href="./references#MR000032-fig-0028" title="">Analysis 23.1</a>, <a href="./full#MR000032-tbl-0010">summary of findings Table 10</a> ). This result is based on four studies, n = 3765: <a href="./references#MR000032-bbs2-0009" title="BradshawLE , MontgomeryAA , WilliamsHC , ChalmersJR , HainesRH . Two-by-two factorial randomised study within a trial (SWAT) to evaluate strategies for follow-up in a randomised prevention trial. Trials.2020;21(1):529. [DOI: 10.1186/s13063-020-04373-4]">Bradshaw 2020</a> (eczema), <a href="./references#MR000032-bbs2-0020" title="DorlingJ , HewerO , HurdM , BariV , BosiakB , BowlerU , et al. Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT. Health Technology Assessment2020;24(81):1-94. [DOI: 10.3310/hta24180]">Dorling 2020</a> (infant feeding), <a href="./references#MR000032-bbs2-0015" title="CookJ , CookJA , BongardE , HeneghanC , Butler CC. SWAT 90 evaluation: Does the time at which a participant incentive is given affect the retention rate?https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,902359,en.pdf. [16406421]">Cook 2020</a> (influenza), <a href="./references#MR000032-bbs2-0072" title="YoungB , BedfordL , das NairR , GallantS , LittlefordR , RobertsonJF , et al. Unconditional and conditional monetary incentives to increase response to mailed questionnaires: A randomized controlled study within a trial (SWAT). Journal of Evaluation in Clinical Practice2020;26(3):893-902. [DOI: 10.1111/jep.13230]">Young 2020</a> (lung cancer screening) . </p> </li> <li> <p>The evidence is very uncertain about the effect of the addition of a monetary reward compared to usual follow‐up on retention: RD = 2% (95% CI ‐3% to 6%); GRADE: very low; (<a href="./references#MR000032-fig-0029" title="">Analysis 24.1</a>, <a href="./full#MR000032-tbl-0011">summary of findings Table 11</a>). This result is based on three studies, n = 1159: <a href="./references#MR000032-bbs2-0047" title="MarshP , KendrickD . Using a diary to record near misses and minor injuries?which method of administration is best?Injury Prevention1999;5:305-9. ">Marsh 1999</a> (injury prevention), <a href="./references#MR000032-bbs2-0070" title="WatsonAJ , CookJ , HudsonJ , KilonzoM , WoodJ , BruhnH , et al. A pragmatic multicentre randomised controlled trial comparing stapled haemorrhoidopexy with traditional excisional surgery for haemorrhoidal disease: the eTHoS study. Health Technology Assessment2017;21(70):1-224. [DOI: 10.3310/hta21700]">Watson 2017</a> (haemorrhoids) and focus on return of postal questionnaires and found no effect: RD = 0% (95% CI ‐6% to 7%). The third study, <a href="./references#MR000032-bbs2-0002" title="ArundelC , ColemanE , FairhurstC , PeckhamE , BaileyD , GilbodyS . The effectiveness of a contingent financial incentive to improve trial follow up; a randomised study within a trial (SWAT). F1000Research2019;8:1937. [DOI: 10.12688/f1000research.21059.2]">Arundel 2019</a> (smoking cessation), shows an effect on attendance at follow‐up visits. A sensitivity analysis excluding the quasi‐randomised trial (<a href="./references#MR000032-bbs2-0047" title="MarshP , KendrickD . Using a diary to record near misses and minor injuries?which method of administration is best?Injury Prevention1999;5:305-9. ">Marsh 1999</a>) showed a similar effect on retention with sustained uncertainty in the evidence: RD 1%, 95% CI ‐4% to 6%: GRADE: very low (<a href="./references#MR000032-fig-0030" title="">Analysis 24.2</a>). </p> </li> <li> <p>Addition of a monetary reward to both trial arms delivered either with the prenotification or with the reminder letter, probably increases retention: <a href="./references#MR000032-bbs2-0033" title="HardyP , BellJL , BrocklehurstP , Epidural and Position Trial Collaborative Group. Evaluation of the effects of an offer of a monetary incentive on the rate of questionnaire return during follow-up of a clinical trial: a randomised study within a trial. BMC Medical Research Methodology2016;16:82. [DOI: 10.1186/s12874-016-0180-9]">Hardy 2016</a> (labour): RD = 9% (95% CI 3% to 15%); GRADE moderate (‐1 level: imprecision‐single study, n = 1018) (<a href="./references#MR000032-fig-0031" title="">Analysis 25.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of the addition of a monetary incentive compared to inclusion in a lottery: <a href="./references#MR000032-bbs2-0037" title="KentonL , DennisCL , WestonJ , KissA . The effect of incentives and high priority mailing on postal questionnaire response rates: a mini-RCT. In: Abstracts from the 28th Meeting of the Society of Clinical Trials; 2007 May 20-23; Montreal. Vol. 4. 2007:371-455. ">Kenton 2007</a>, (postnatal depression): RD = 2% (95% CI ‐9% to 12%);GRADE very low (‐1 level: study limitations– unclear risk of bias;‐2 levels: imprecision‐single study, n = 281; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0032" title="">Analysis 26.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of inclusion in a lottery compared to usual follow‐up: <a href="./references#MR000032-bbs2-0034" title="HendersonM , WightD , NixonC , HartG . Retaining young people in a longitudinal sexual health survey: a trial of strategies to maintain participation. BMC Medical Research Methodology2010;10:9. [DOI: 10.1186/1471-2288-10-9]">Henderson 2010</a> (sexual health): RD = ‐1% (95% CI ‐3% to 2%); GRADE very low (‐1 level: study limitations– unclear risk of bias;‐2 levels: imprecision‐single study, n = 4206; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0033" title="">Analysis 27.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of inclusion in a high‐ versus low‐value lottery: <a href="./references#MR000032-bbs2-0034" title="HendersonM , WightD , NixonC , HartG . Retaining young people in a longitudinal sexual health survey: a trial of strategies to maintain participation. BMC Medical Research Methodology2010;10:9. [DOI: 10.1186/1471-2288-10-9]">Henderson 2010</a> (sexual health): RD = 2% (95% CI ‐1% to 6%); GRADE very low (‐1 level: study limitations– unclear risk of bias;‐2 levels: imprecision‐single study, n = 2758; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0034" title="">Analysis 28.1</a>). </p> </li> </ol> </p> <p><i>Non‐monetary incentives</i> </p> <p> <ol id="MR000032-list-0019"> <li> <p>Addition of a pen compared to no pen may increase retention slightly: RD = 2% (95% CI 0% to 4%); GRADE: low; (<a href="./references#MR000032-fig-0035" title="">Analysis 29.1</a>, <a href="./full#MR000032-tbl-0012">summary of findings Table 12</a> ). This result is based on five studies, n = 13,013: <a href="./references#MR000032-bbs2-0054" title="MitchellAS , CookL , DeanA , FairhurstC , NorthgravesM , TorgersonD , et al. Using pens as an incentive for questionnaire return in an orthopaedic trial: an embedded randomised controlled retention trial. F1000Research2020;9:321. [DOI: 10.12688/f1000research.23018.1]">Mitchell 2020a</a> (knee replacement), <a href="./references#MR000032-bbs2-0035" title="JamesS , ParkerA , CockayneS , RodgersS , FairhurstC , TorgersonD , et al. Including a pen and/or cover letter, containing social incentive text, had no effect on questionnaire response rate: a factorial randomised controlled Study within a Trial. F1000Research2020;9:623. [DOI: 10.12688/f1000research.23767.1]">James 2020</a> (falls prevention), <a href="./references#MR000032-bbs2-0008" title="BellK , ClarkL , FairhurstC , MitchellN , LenaghanE , BlacklockJ , et al. Enclosing a pen reduced time to response to questionnaire mailings. Journal of Clinical Epidemiology2016;74:144-50. [DOI: 10.1016/j.jclinepi.2015.]">Bell 2016</a> (fracture prevention), <a href="./references#MR000032-bbs2-0018" title="Cunningham-BurleyR , RocheJ , FairhurstC , CockayneS , HewittC , Iles-SmithH , et al, SSHeW Study Team. Enclosing a pen to improve response rate to postal questionnaire: an embedded randomised controlled trial. F1000Research2020;9:577. [DOI: 10.12688/f1000research.23651.1]">Cunningham‐Burley 2020</a> (falls prevention), and <a href="./references#MR000032-bbs2-0063" title="SharpL , CochranC , CottonSC , GrayNM , GallagherME , TOMBOLA group. Enclosing a pen with a postal questionnaire can significantly increase the response rate. Journal of Clinical Epidemiology2006;59(7):747-54. [DOI: 10.1016/j.jclinepi.2005.10.014]">Sharp 2006</a> (cervical screening). </p> </li> <li> <p>Inclusion of a societal benefit message compared to usual follow‐up may result in little or no difference to retention: <a href="./references#MR000032-bbs2-0062" title="SeveriE , FreeC , KnightR , RobertsonS , EdwardsP , HoileE . Two controlled trials to increase participant retention in a randomized controlled trial of mobile phone-based smoking cessation support in the United Kingdom. Clinical Trials2011;8(5):654-60. [DOI: 10.1177/1740774511416524]">Severi 2011</a> (smoking cessation): RD = ‐0% (95% CI ‐4% to 4%); GRADE low (‐2 levels: imprecision‐single study, n = 1950; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0036" title="">Analysis 30.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of providing a certificate of appreciation compared to no certificate: <a href="./references#MR000032-bbs2-0058" title="RenfroeEG , HeywoodG , ForemanL , SchronE , PowellJ , BaesslerC , et al. The end-of-study patient survey: methods influencing response rate in the AVID trial. Controlled Clinical Trials2002;23(5):521-33. RenfroeEG , PowellJ , OlarteA , MorrisM , HallstromA . Method of administering patient surveys affects response rate. Controlled Clinical Trials1999;20:s62. [DOI: 10.1016/s0197-2456(02)00225-8]">Renfroe 2002</a> (arrhythmia): RD = ‐5% (95% CI ‐13% to 3%); GRADE very low (‐1 level: study limitations– unclear risk of bias;‐2 levels: imprecision‐single study, n = 479; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0037" title="">Analysis 31.1</a>). </p> </li> </ol> </p> <p><i>Maintaining participant engagement</i> </p> <p> <ol id="MR000032-list-0020"> <li> <p>The evidence is very uncertain about the effect on retention of including a newsletter compared to no newsletter: RD = ‐0% (95% CI ‐4% to 3%); GRADE: very low; (<a href="./references#MR000032-fig-0038" title="">Analysis 32.1</a>, <a href="./full#MR000032-tbl-0013">summary of findings Table 13</a>). This result is based on four studies, n = 5622: <a href="./references#MR000032-bbs2-0028" title="GoulaoB , DuncanA , FloateR , ClarksonJ , RamsayC . Three behavior change theory-informed randomized studies within a trial to improve response rates to trial postal questionnaires. Journal of Clinical Epidemiology2020;122:35-41. [DOI: 10.1016/j.jclinepi.2020.01.018]">Goulao 2020</a> (dentistry), <a href="./references#MR000032-bbs2-0053" title="MitchellN , HewittCE , LenaghanE , PlattE , ShepstoneL , TorgersonDJ , SCOOP study team. Prior notification of trial participants by newsletter increased response rates: a randomized controlled trial. Journal of Clinical Epidemiology2012;65(12):1348-52. [DOI: 10.1016/j.jclinepi.2012.05.008]">Mitchell 2012</a> (fracture prevention), <a href="./references#MR000032-bbs2-0059" title="RodgersS , SbizzeraI , CockayneS , FairhurstC , LambSE , VernonW , et al. A study update newsletter or Post-it® note did not increase postal questionnaire response rates in a falls prevention trial: an embedded randomised factorial trial. F1000Research2019;7:1083. [DOI: 10.12688/f1000research.14591.2]">Rodgers 2019</a> (fall prevention), and <a href="./references#MR000032-bbs2-0044" title="BeasleyM . MamMOTH trial. Personal communication. ">MamMOTH 2020</a> (chronic pain). </p> </li> <li> <p>The offer of recieving the results of the resutls of the trial compared to no offer may result in little to no difference to retention based on very uncertian evidence: <a href="./references#MR000032-bbs2-0013" title="CockayneS , TorgersonD . A randomised controlled trial to assess the effectiveness of offering study results as an incentive to increase response rates to postal questionnaires. BMC Medical Research Methodology2005;5(1):34. ">Cockayne 2005</a> (fracture prevention): RD = ‐2% (95% CI ‐5% to 2%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 1038; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0039" title="">Analysis 33.1</a>). </p> </li> <li> <p>Including a social incentive (e.g. personalised table of questionnaire response to date to evidence previous responses noted and valued) in the cover letter compared to the standard cover letter may result in little or no difference to retention <a href="./references#MR000032-bbs2-0035" title="JamesS , ParkerA , CockayneS , RodgersS , FairhurstC , TorgersonD , et al. Including a pen and/or cover letter, containing social incentive text, had no effect on questionnaire response rate: a factorial randomised controlled Study within a Trial. F1000Research2020;9:623. [DOI: 10.12688/f1000research.23767.1]">James 2020</a> (falls prevention): RD = ‐1% (95% CI ‐4% to 2%); GRADE low (‐2 levels: imprecision‐single study, n = 755; wide CI crossing RD=) (<a href="./references#MR000032-fig-0040" title="">Analysis 34.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of varying the signatory on cover letters: <a href="./references#MR000032-bbs2-0058" title="RenfroeEG , HeywoodG , ForemanL , SchronE , PowellJ , BaesslerC , et al. The end-of-study patient survey: methods influencing response rate in the AVID trial. Controlled Clinical Trials2002;23(5):521-33. RenfroeEG , PowellJ , OlarteA , MorrisM , HallstromA . Method of administering patient surveys affects response rate. Controlled Clinical Trials1999;20:s62. [DOI: 10.1016/s0197-2456(02)00225-8]">Renfroe 2002</a> (arrhythmia): RD = 2% (95% CI ‐6% to 10%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 479; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0041" title="">Analysis 35.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of including a deadline for completion versus no deadline, <a href="./references#MR000032-bbs2-0026" title="GattellariM , WardJE . Does a deadline improve men's participation in self-administered health surveys? A randomized controlled trial in general practice. Journal of Public Health2004;26(4):384-7. [DOI: 10.1093/pubmed/fdh177]">Gattellari 2004</a> (prostate cancer): RD = 4% (95% CI ‐5% to 12%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 246; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0042" title="">Analysis 36.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of adding an estimate of time to completion versus no addition: <a href="./references#MR000032-bbs2-0048" title="MarsonAG . A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs: the SANAD trial. NIHR HTA Report2007;11(37):111-3. [DOI: 10.3310/hta11370]">Marson 2007</a> (epilepsy): RD = 1% (95% CI ‐2% to 4%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 1815; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0043" title="">Analysis 37.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of comparing brown to white envelopes: <a href="./references#MR000032-bbs2-0052" title="MitchellN , HewittCE , TorgersonDJ , SCOOP Trial Group. A controlled trial of envelope colour for increasing response rates in older women. Aging Clinical and Experimental Research2011;23(3):236-40. [DOI: 10.1007/bf03337749]">Mitchell 2011</a> (fracture prevention): RD = 2% (95% CI ‐1% to 5%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 1119; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0044" title="">Analysis 38.1</a>). </p> </li> <li> <p>Addition of a post‐it note compared to no post‐it note or alternative post‐it notes may result in little or no difference to retention: RD = 0% (95% CI ‐1% to 1%); GRADE low; (<a href="./references#MR000032-fig-0045" title="">Analysis 39.1</a>, <a href="./full#MR000032-tbl-0014">summary of findings Table 14</a>). This result is based on eight trials from three studies, n = 4698: <a href="./references#MR000032-bbs2-0059" title="RodgersS , SbizzeraI , CockayneS , FairhurstC , LambSE , VernonW , et al. A study update newsletter or Post-it® note did not increase postal questionnaire response rates in a falls prevention trial: an embedded randomised factorial trial. F1000Research2019;7:1083. [DOI: 10.12688/f1000research.14591.2]">Rodgers 2019</a> (fall prevention), <a href="./references#MR000032-bbs2-0041" title="LewisH , KedingA , BosanquetK , GilbodyS , TorgersonD . An randomized controlled trial of Post-it® notes did not increase postal response rates in older depressed participants. Journal of Evaluation in Clinical Practice2017;23(1):102-7. [DOI: 10.1111/jep.12618]">Lewis 2017</a> (depression), and <a href="./references#MR000032-bbs2-0067" title="TilbrookHE , BecqueT , BuckleyH , MacPhersonH , BaileyM , TorgersonDJ . Randomized trial within a trial of yellow 'post-it notes' did not improve questionnaire response rates among participants in a trial of treatments for neck pain. Journal of Evaluation in Clinical Practice2015;21(2):202-4. [DOI: 10.1111/jep.12284]">Tilbrook 2015</a> (neck pain). </p> </li> <li> <p>Inclusion of a newspaper article about the trial compared to no article may increase retention: <a href="./references#MR000032-bbs2-0060" title="Salvesen KA adn VattenLJ . Effect of a newspaper article on the response to a postal questionnaire. Journal of Epidemiology and Community Health1992;46(1):86. [DOI: 10.1136/jech.46.1.86]">Salvesen 1992</a> (pregnancy): RD = 8% (95% CI 1% to 15%); GRADE low (‐1 level: study limitations– unclear risk of bias; ‐1 level: imprecision‐single study, n = 716) (<a href="./references#MR000032-fig-0046" title="">Analysis 40.1</a>). </p> </li> <li> <p>Frequency of telephone contact comparing only at baseline to annual contact to contact only at baseline may increase retention: <a href="./references#MR000032-bbs2-0027" title="GlassmanAR , BeaulieuWT , StockdaleCR , BeckRW , BresslerNM , LabriolaLT , et al. Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial. Clinical Trials2020;17(2):195-201. [DOI: 10.1177/1740774519894229]">Glassman 2020</a> (diabetic retinopathy): RD = 8% (95% CI 1% to 15%); GRADE low (‐1 level: study limitations– unclear risk of bias; ‐1 level: imprecision‐single study, n = 305) (<a href="./references#MR000032-fig-0047" title="">Analysis 41.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of a request for a collateral (i.e. a contact person) compared to no request or request with 50% chance of contact: <a href="./references#MR000032-bbs2-0017" title="CunninghamJA , WildTC , CordingleyJ . Using collaterals to validate self-reports of problem drinkers: any impact on client attrition and quantity of drinking reported?Addictive Behaviors2004;29(3):615-21. [DOI: 10.1016/j.addbeh.2003.08.023]">Cunningham 2004</a> (alcohol consumption): RD = 7% (95% CI ‐1% to 16%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 408; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0048" title="">Analysis 42.1</a>). </p> </li> </ol> </p> <p><i>Behavioural interventions</i> </p> <p> <ol id="MR000032-list-0021"> <li> <p>The evidence is very uncertain about the effect on retention of a theory informed cover letter compared to a usual cover letter: RD = 3% (95% CI ‐2% to 8%); GRADE very low; (<a href="./references#MR000032-fig-0049" title="">Analysis 43.1</a>, <a href="./full#MR000032-tbl-0015">summary of findings Table 15</a>). This result is based on four trials, n = 3343 from three studies: <a href="./references#MR000032-bbs2-0028" title="GoulaoB , DuncanA , FloateR , ClarksonJ , RamsayC . Three behavior change theory-informed randomized studies within a trial to improve response rates to trial postal questionnaires. Journal of Clinical Epidemiology2020;122:35-41. [DOI: 10.1016/j.jclinepi.2020.01.018]">Goulao 2020</a>, <a href="./references#MR000032-bbs2-0029" title="GoulaoB , DuncanA , FloateR , ClarksonJ , RamsayC . Three behavior change theory-informed randomized studies within a trial to improve response rates to trial postal questionnaires. Journal of Clinical Epidemiology2020;122:35-41. [DOI: 10.1016/j.jclinepi.2020.01.018]">Goulao 2020 (replication of SWAT #2)</a> (both dentistry), <a href="./references#MR000032-bbs2-0057" title="Goodman K. Evaluation of theory informed cover letter compared to standard cover letter.. Personal communication. ">OPAL 2020</a> (urinary incontinence), and <a href="./references#MR000032-bbs2-0001" title="Hagen S. Evaluation of theory informed cover letetr comapred to standard cover letter. Personal Communication. ">AMBER 2020</a> (multiple sclerosis). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of motivational interviewing compared to usual follow‐up: <a href="./references#MR000032-bbs2-0007" title="BeanMK , ThorntonLM , JeffersAJ , GowRW , MazzeoSE . Impact of motivational interviewing on engagement in a parent-exclusive paediatric obesity intervention: randomized controlled trial of NOURISH+MI. Pediatric Obesity2019;14(4):e12484. [DOI: 10.1111/ijpo.12484]">Bean 2019</a> (childhood obesity): RD = 0% (95% CI ‐17% to 17%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 128; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0050" title="">Analysis 44.1</a>). </p> </li> </ol> </p> <p><b>Sites and site staff ‐ Category C (</b><a href="#MR000032-tbl-0020">Table 4</a>) </p> <p>Two studies assessed interventions, grouped into two comparisons, aimed at trial sites. One, a cluster‐randomised trial but reporting data on questionnaires returned (<a href="./references#MR000032-bbs2-0040" title="LandSR , RitterMW , CostantinoJP , JulianTB , CroninWM , HaileSR , et al. Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches. Journal of Clinical Oncology2007;25(32):5113-20. [DOI: 10.1200/jco.2007.12.1749]">Land 2007</a>) and the other an individually‐randomised trial reporting submission of case report forms by sites (<a href="./references#MR000032-bbs2-0042" title="LiénardJL , QuinauxE , Fabre-GuillevinE , PiedboisP , JouhaudA , DecosterG , et al. Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancer. Clinical Trials2006;3(5):486-92. [DOI: 10.1177/1740774506070807]">Lienard 2006</a>). </p> <p><i>Prompts</i> </p> <p> <ol id="MR000032-list-0022"> <li> <p>The evidence is very uncertain about the effect on retention of prompts targeting sites for upcoming assessment compared to no prompts: <a href="./references#MR000032-bbs2-0040" title="LandSR , RitterMW , CostantinoJP , JulianTB , CroninWM , HaileSR , et al. Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches. Journal of Clinical Oncology2007;25(32):5113-20. [DOI: 10.1200/jco.2007.12.1749]">Land 2007</a> (breast cancer prevention): RD = ‐3% (95% CI ‐13% to 7%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0051" title="">Analysis 45.1</a>). </p> </li> </ol> </p> <p><i>Monitoring visits</i> </p> <p> <ol id="MR000032-list-0023"> <li> <p>The evidence is very uncertain about the effect on retention of on site monitoring compared to no visits: <a href="./references#MR000032-bbs2-0042" title="LiénardJL , QuinauxE , Fabre-GuillevinE , PiedboisP , JouhaudA , DecosterG , et al. Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancer. Clinical Trials2006;3(5):486-92. [DOI: 10.1177/1740774506070807]">Lienard 2006</a> (breast cancer treatment): RD = ‐5% (95% CI ‐20% to 10%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 69; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0052" title="">Analysis 46.1</a>). </p> </li> </ol> </p> <p><b>Central Study Management ‐ Category D (</b><a href="#MR000032-tbl-0021">Table 5</a>) </p> <p>Only one study (<a href="./references#MR000032-bbs2-0024" title="FouadMN , JohnsonRE , NagyMC , PersonSD , PartridgeEE . Adherence and retention in clinical trials: a community-based approach. Cancer2014;120 Suppl 7:1106-12. [DOI: 10.1002/cncr.28572]">Fouad 2014</a>) assessed the effect of a central study management intervention on retention. This study was judged to be at unclear risk of bias and involved 632 participants. </p> <p><i>Patient Public Involvement</i> </p> <p> <ol id="MR000032-list-0024"> <li> <p>A peer‐led follow‐up strategy compared to usual follow‐up may result in a large increase in retention: <a href="./references#MR000032-bbs2-0024" title="FouadMN , JohnsonRE , NagyMC , PersonSD , PartridgeEE . Adherence and retention in clinical trials: a community-based approach. Cancer2014;120 Suppl 7:1106-12. [DOI: 10.1002/cncr.28572]">Fouad 2014</a> (cervical cancer): RD = 22% (95% CI 14% to 30%); GRADE low (‐1 level: study limitations– unclear risk of bias; ‐1 levels: imprecision‐single study, n = 632) (<a href="./references#MR000032-fig-0053" title="">Analysis 47.1</a>). </p> </li> </ol> </p> <p><b>Study design ‐ Category E (</b><a href="#MR000032-tbl-0022">Table 6</a>) </p> <p>Five studies across two comparisons evaluated five interventions targeting aspects of study design. These comparisons included 2160 participants. </p> <p><i>Impact of recruitment</i> </p> <p> <ol id="MR000032-list-0025"> <li> <p>The evidence is very uncertain about the effect on retention of video‐enhanced patient information compared to standard information: <a href="./references#MR000032-bbs2-0010" title="BrubakerL , JelovsekJE , LukaczES , BalgobinS , BallardA , WeidnerAC , et al. Recruitment and retention: a randomized controlled trial of video-enhanced versus standard consent processes within the E-OPTIMAL study. Clinical Trials2019;16(5):481-9. [DOI: 10.1177/1740774519865541]">Brubaker 2019</a> (urinary incontinence): RD = 3% (95% CI ‐5% to 12%); GRADE very low (‐1 level: study limitations– unclear risk of bias; ‐2 levels: imprecision‐single study, n = 285; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0054" title="">Analysis 48.1</a>). </p> </li> <li> <p>The evidence is very uncertain about the effect on retention of optimised patient information compared to standard patient information: RD = ‐3% (95% CI ‐13% to 7%); GRADE: very low; (<a href="./references#MR000032-fig-0055" title="">Analysis 49.1</a>, <a href="./full#MR000032-tbl-0016">summary of findings Table 16</a>). This result is based two studies, n = 1285: <a href="./references#MR000032-bbs2-0014" title="CockayneS , FairhurstC , AdamsonJ , HewittC , HullR , HicksK , et al. An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trial. Trials2017;18(1):144. [DOI: 10.1186/s13063-017-1797-7]">Cockayne 2017</a> (falls prevention) and <a href="./references#MR000032-bbs2-0032" title="GuarinoP , ElbourneD , CarpenterJ , PeduzziP . Consumer involvement in consent document development: a multicenter cluster randomized trial to assess study participants' understanding. Clinical Trials2006;3(1):19-30. [DOI: 10.1191/1740774506cn133oa]">Guarino 2006</a> (Gulf War Syndrome). </p> </li> <li> <p>The addition of optimised information, either as bespoke or template formats, may increase retention: <a href="./references#MR000032-bbs2-0014" title="CockayneS , FairhurstC , AdamsonJ , HewittC , HullR , HicksK , et al. An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trial. Trials2017;18(1):144. [DOI: 10.1186/s13063-017-1797-7]">Cockayne 2017</a> (falls prevention): RD = 6% (95% CI ‐7% to 20%); GRADE low (‐2 levels: imprecision‐single study, n = 131; wide CI crossing RD = 0) (<a href="./references#MR000032-fig-0056" title="">Analysis 50.1</a>). </p> </li> <li> <p>Giving a pen at recruitment compared to no pen probably increases retention: <a href="./references#MR000032-bbs2-0071" title="WhitesideK , FlettL , MitchellA , FairhurstC , CockayneS , RodgersS , et al, OTIS Study Group. Using pens as an incentive for trial recruitment of older adults: An embedded randomised controlled trial. F1000Research2019;8:315. [DOI: 10.12688/f1000research.18300.1]">Whiteside 2019</a> (falls prevention): RD = 20% (95% CI 7% to 32%); GRADE moderate (‐1 level: imprecision‐single study, n = 92) (<a href="./references#MR000032-fig-0057" title="">Analysis 51.1</a>). </p> </li> </ol> </p> <p><i>Blinding and treatment preference</i> </p> <p> <ol id="MR000032-list-0026"> <li> <p>Randomising participants at recruitment to an open rather than a blinded trial may result in a large increase in retention: <a href="./references#MR000032-bbs2-0004" title="AvenellA , GrantAM , McGeeM , McPhersonG , CampbellMK , McGeeMA , et al. The effects of an open design on trial participant recruitment, compliance and retention - a randomized controlled trial comparison with a blinded, placebo-controlled design. Clinical Trials2004;1(6):490-8. [DOI: 10.1191/1740774504cn053oa]">Avenell 2004</a> (fracture prevention): RD = 13% (95% CI 4% to 22%); GRADE low (‐1 level: study limitations– unclear risk of bias; ‐1 level: imprecision‐single study, n = 367) (<a href="./references#MR000032-fig-0058" title="">Analysis 52.1</a>). </p> </li> </ol> </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="MR000032-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="MR000032-sec-0039"></div> <section id="MR000032-sec-0040"> <h3 class="title" id="MR000032-sec-0040">Principal findings</h3> <p>As it stands, there is nothing in the evidence base with high‐certainty evidence (as determined by GRADE) that can be applied to trials to improve trial retention. Four interventions have moderate‐certainty evidence, although one of them (adding a diary to usual follow‐up) probably reduces retention. Given the frequency with which diaries are used in trials, this is a useful piece of information. The bulk of all retention intervention evidence is rated as low or very low certainty using GRADE. Whilst there are replications of a few interventions, most (33 of 51 comparisons) have been evaluated in a single study. However, what is more encouraging is that of the 68 studies identified, 33 of those have been published in the last five years, indicating a ground swell in efforts for evaluations of interventions to improve trial retention. Now, the focus needs to be on more joined up rigorous evaluations of existing or priority interventions to industrialise the evidence generation in this area. </p> <p>The previous version of this Cochrane Review identified monetary incentives as an effective strategy for improving return of postal questionnaires (<a href="./references#MR000032-bbs2-0215" title="BruetonVC , TierneyJ , StenningS , HardingS , MeredithS , NazarethI , et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: MR000032. [DOI: 10.1002/14651858.MR000032.pub2]">Brueton 2013</a>). Whilst the overall findings remained the same in this update (addition of a monetary incentive compared to usual follow‐up) with an improvement in retention (RD: 7% (95% CI 4% to 11%), the overall certainty in the evidence was assessed as low, largely due to two of the three studies in this comparison being assessed as high risk of bias. Therefore, further replications of the evaluation of monetary incentive compared to no monetary incentive are still required in well‐designed studies. Also, mirroring the previous version of this Cochrane Review (<a href="./references#MR000032-bbs2-0215" title="BruetonVC , TierneyJ , StenningS , HardingS , MeredithS , NazarethI , et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: MR000032. [DOI: 10.1002/14651858.MR000032.pub2]">Brueton 2013</a>), this update predominantly identified studies that aimed to improve questionnaire return with a very small proportion (3%, n = 2) of all included studies targeting clinic attendance. There may be several reasons for this large evidence gap. Firstly, many trials that collect patient‐reported outcome data do so through self‐completion of questionnaires which can be administered remotely. It may also be perceived that return of a questionnaire is an easier behaviour to target and change than attending a clinic follow‐up visit. However, as face‐to‐face visits are central to many, perhaps most, trials there is a critical need to identify effective ways to enhance clinic follow‐up. One suggestion could be to identify high‐quality evidence for interventions that have been shown to improve clinic attendance at clinical care appointments and evaluate them for use in a trial setting e.g. electronic text notifications (<a href="./references#MR000032-bbs2-0202" title="RobothamD , SatkunanathanS , ReynoldsJ , StahlD , WykesT . Using digital notifications to improve attendance in clinic: systematic review and meta-analysis. BMJ Open2016;6(10):e012116. [DOI: 10.1136/bmjopen-2016-012116]">Robotham 2016</a>). Examining systematic reviews of factors known to affect retention (e.g. <a href="./references#MR000032-bbs2-0205" title="SkeaZC , NewlandsR , GilliesK . Exploring non-retention in clinical trials: a meta-ethnographic synthesis of studies reporting participant reasons for drop out. BMJ Open2019;9(6):e021959. [DOI: 10.1136/bmjopen-2018-021959]">Skea 2019</a>), such as the compatibility of trial processes with participants’ capabilities, would provide targets for well‐designed future interventions. </p> <p>Some comparisons with low‐certainty evidence should be considered for future replication studies to help improve the overall certainty in the evidence (see <a href="#MR000032-sec-0043">Implications for methodological research</a>). For example: return postage strategies (<a href="./references#MR000032-fig-0012" title="">Analysis 8.1</a>); addition of a pen versus no pen (<a href="./references#MR000032-fig-0035" title="">Analysis 29.1</a>); and electronic reminders compared to usual follow‐up (<a href="./references#MR000032-fig-0014" title="">Analysis 10.1</a>). There is also merit in conducting replication of interventions evaluated in single studies, especially where the single studies have moderate‐certainty evidence and potentially large overall effect sizes, such as: giving a pen at recruitment (<a href="./references#MR000032-fig-0057" title="">Analysis 51.1</a>), and addition of monetary rewards to both trial arms (<a href="./references#MR000032-fig-0031" title="">Analysis 25.1</a>). </p> <p>Many of these comparisons and single‐study evaluations offer improvements in the region of 1% to 7%, the latter of which we would consider a moderate effect size. However, one of the included studies (GRADE low) which evaluated a peer‐led intervention to improve retention in a cervical screening trial found an overall improvement of 22% (<a href="./references#MR000032-fig-0053" title="">Analysis 47.1</a>), which we would consider a large effect size. This should also be a focus for future evaluation. A single additional study could improve the GRADE assessment to moderate if the results were consistent with the existing study. Although these patient and public involvement (PPI) interventions are likely to be more costly to develop and implement, if the gains seen are replicable, the benefit of a large effect may outweigh the costs. This is especially true where poor retention is dealt with by inflating the recruitment target to compensate for future expected loss‐to‐follow‐up; given that recruitment is both difficult and expensive. Future evaluations and development of interventions should also consider how to meaningfully include patient and public partners in these embedded evaluations of retention interventions. Ensuring the interventions are embedded in trial participants’ accounts of barriers to retention will be key to developing interventions that target what actually matters to trial participants. </p> <p>PPI interventions and their impact on trial retention was identified as one of the Top 10 research questions from a James Lind Priority Setting Partnership exercise to identify the unanswered questions for trial retention (<a href="./references#MR000032-bbs2-0186" title="BrunsdonD , BiestyL , BrocklehurstP , BruetonV , DevaneD , ElliottJ , et al. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study. Trials2019;20(1):593. [DOI: 10.1186/s13063-019-3687-7]">Brunsdon 2019</a>). Many of the evaluations in this update fit within some of those questions but they tend to cluster around question 4 "What are the best ways to encourage trial participants to compete the tasks (e.g. attend follow‐up visits, complete questionnaires) required by the trial?". There are still very few evaluations of how to encourage participants to attend clinic visits and the same can be said for interventions targeting trial staff involved with retention. </p> <p>We are hopeful that through key initiatives such as the PROMETHEUS (PROMoting THE USe of SWATs) project that collaborative efforts in this area will ensure that high‐quality evaluations of retention interventions are conducted in a timely manner (<a href="./references#MR000032-bbs2-0200" title="PROMETHEUS. https://www.york.ac.uk/healthsciences/research/trials/research/swats/prometheus/.">PROMETHEUS</a>). More so, specific support from funders such as the National Institute for Health Research Health Technology Assessment Programme (UK) and the Health Research Board (Ireland) to provide funding for embedding these evaluations within ongoing trials should encourage trial teams to ensure they develop the evidence base whilst delivering their trials. Future evaluations (of any retention intervention) should also consider economic evaluation. Some trials included in this review did consider cost, with some authors hypothesising what the overall cost reduction could be for the strategy as a whole and others providing more clear examples of cost‐effectiveness by demonstrating cost per additional person retained. For example, <a href="./references#MR000032-bbs2-0025" title="GatesS , WilliamsM , WithersE , WilliamsonE , Mt-IsaS , LambS . Does a monetary incentive improve the response to a postal questionnaire in a randomised controlled trial? The MINT incentive study. Trials2009;10(1):44. [DOI: 10.1186/1745-6215-10-44]">Gates 2009</a> demonstrated that their use of monetary incentives cost £67.29 for every questionnaire returned. Similarly, <a href="./references#MR000032-bbs2-0018" title="Cunningham-BurleyR , RocheJ , FairhurstC , CockayneS , HewittC , Iles-SmithH , et al, SSHeW Study Team. Enclosing a pen to improve response rate to postal questionnaire: an embedded randomised controlled trial. F1000Research2020;9:577. [DOI: 10.12688/f1000research.23651.1]">Cunningham‐Burley 2020</a> demonstrated the cost of using a pen to retain an extra participant was £10.56. These two examples show the potential difference in costs of implementing retention interventions (both for evaluation and in practice) and, therefore, cost is an important outcome for evaluators to include in future comparisons so as to provide trial teams with the information they need to make a decision on what will work from an effectiveness and an economic perspective. </p> <p>Finally, we welcome notifications for missed or newly published studies that require inclusion in future updates of this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="MR000032-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-FIG-01" target="_blank"><b></b></a></p> </div><img alt="1 Included studies flow diagram." data-id="MR000032-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>1 Included studies flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="MR000032-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="MR000032-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: A ‐ Questionnaire Design: Short vs usual questionnaire, Outcome 1: Retention" data-id="MR000032-fig-0004" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: A ‐ Questionnaire Design: Short vs usual questionnaire, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: A ‐ Questionnaire Design: Addition of diary to usual follow up vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0005" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: A ‐ Questionnaire Design: Addition of diary to usual follow up vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: A ‐ Questionnaire Design: Question order, condition first vs generic first questions, Outcome 1: Retention" data-id="MR000032-fig-0006" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: A ‐ Questionnaire Design: Question order, condition first vs generic first questions, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: A ‐ Data Collection Frequency and Timing: Timing of questionnaire delivery, Outcome 1: Retention" data-id="MR000032-fig-0007" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: A ‐ Data Collection Frequency and Timing: Timing of questionnaire delivery, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: A ‐ Data Collection Location and Method: Postal follow‐up vs clinic follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0008" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: A ‐ Data Collection Location and Method: Postal follow‐up vs clinic follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: A ‐ Data Collection Location and Method: Telephone follow‐up vs postal questionnaire, Outcome 1: Retention" data-id="MR000032-fig-0009" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: A ‐ Data Collection Location and Method: Telephone follow‐up vs postal questionnaire, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: A ‐ Data Collection Location and Method: Telephone follow‐up vs postal questionnaire, Outcome 2: Retention ‐ sensitivity analysis removing quasi‐RCTs" data-id="MR000032-fig-0010" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: A ‐ Data Collection Location and Method: Telephone follow‐up vs postal questionnaire, Outcome 2: Retention ‐ sensitivity analysis removing quasi‐RCTs </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: A ‐ Data Collection Location and Method: First class vs second class outward mailing, Outcome 1: Retention" data-id="MR000032-fig-0011" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: A ‐ Data Collection Location and Method: First class vs second class outward mailing, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: A ‐ Data Collection Location and Method: Return postage, Outcome 1: Retention" data-id="MR000032-fig-0012" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: A ‐ Data Collection Location and Method: Return postage, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: A ‐ Data Collection Location and Method: Use of self‐sampling kits, Outcome 1: Retention" data-id="MR000032-fig-0013" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: A ‐ Data Collection Location and Method: Use of self‐sampling kits, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: B ‐ Reminders: Electronic reminder vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0014" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: B ‐ Reminders: Electronic reminder vs usual follow‐up, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: B ‐ Reminders: Action oriented electronic reminder vs standard electronic reminder, Outcome 1: Retention" data-id="MR000032-fig-0015" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: B ‐ Reminders: Action oriented electronic reminder vs standard electronic reminder, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: B ‐ Reminders: Personalised reminder vs non‐personalised reminder, Outcome 1: Retention" data-id="MR000032-fig-0016" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: B ‐ Reminders: Personalised reminder vs non‐personalised reminder, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-013.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: B ‐ Reminders: Telephone reminder vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0017" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-013.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-013.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13: B ‐ Reminders: Telephone reminder vs usual follow‐up, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-013.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-014.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: B ‐ Reminders: Telephone reminder vs postal reminder, Outcome 1: Retention" data-id="MR000032-fig-0018" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-014.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-014.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14: B ‐ Reminders: Telephone reminder vs postal reminder, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-014.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-015.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 15: B ‐ Prompts: Electronic prompt vs no prompt, Outcome 1: Retention" data-id="MR000032-fig-0019" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-015.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-015.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15: B ‐ Prompts: Electronic prompt vs no prompt, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-015.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-016.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: B ‐ Prompts: Telephone prompt vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0020" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-016.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-016.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16: B ‐ Prompts: Telephone prompt vs usual follow‐up, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-016.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-017.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: B ‐ Prompts: Prenotification card vs no card, Outcome 1: Retention" data-id="MR000032-fig-0021" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-017.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-017.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17: B ‐ Prompts: Prenotification card vs no card, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-017.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-018.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: B ‐ Prompts: Sticker vs no sticker, Outcome 1: Retention" data-id="MR000032-fig-0022" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-018.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-018.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18: B ‐ Prompts: Sticker vs no sticker, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-018.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-019.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: B ‐ Prompts: Personalised prompt vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0023" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-019.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-019.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19: B ‐ Prompts: Personalised prompt vs usual follow‐up, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-019.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-020.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: B ‐ Prompts: Electronic prompts vs electronic reminders, Outcome 1: Retention" data-id="MR000032-fig-0024" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-020.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-020.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20: B ‐ Prompts: Electronic prompts vs electronic reminders, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-020.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-021.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 21: B ‐ Monetary incentives: Addition of monetary incentives vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0025" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-021.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-021.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21: B ‐ Monetary incentives: Addition of monetary incentives vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-021.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-021.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 21: B ‐ Monetary incentives: Addition of monetary incentives vs usual follow‐up, Outcome 2: Retention‐ sensitivity anlysis removing quasi‐RCTs" data-id="MR000032-fig-0026" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-021.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-021.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21: B ‐ Monetary incentives: Addition of monetary incentives vs usual follow‐up, Outcome 2: Retention‐ sensitivity anlysis removing quasi‐RCTs </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-021.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-022.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 22: B ‐ Monetary incentives: Addition of monetary incentives to all trial arms, Outcome 1: Retention" data-id="MR000032-fig-0027" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-022.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-022.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22: B ‐ Monetary incentives: Addition of monetary incentives to all trial arms, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-022.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-023.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 23: B ‐ Monetary incentives: Addition of monetary incentives vs addition of monetary reward, Outcome 1: Retention" data-id="MR000032-fig-0028" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-023.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-023.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.1</div> <div class="figure-caption"> <p>Comparison 23: B ‐ Monetary incentives: Addition of monetary incentives vs addition of monetary reward, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-023.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-024.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 24: B‐ Monetary incentives: Addition of monetary reward vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0029" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-024.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-024.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.1</div> <div class="figure-caption"> <p>Comparison 24: B‐ Monetary incentives: Addition of monetary reward vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-024.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-024.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 24: B‐ Monetary incentives: Addition of monetary reward vs usual follow‐up, Outcome 2: Retention ‐ sensitivity analysis removing quasi‐RCTs" data-id="MR000032-fig-0030" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-024.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-024.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.2</div> <div class="figure-caption"> <p>Comparison 24: B‐ Monetary incentives: Addition of monetary reward vs usual follow‐up, Outcome 2: Retention ‐ sensitivity analysis removing quasi‐RCTs </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-024.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-025.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 25: B ‐ Monetary incentives: Addition of monetary rewards to all trial arms, Outcome 1: Retention" data-id="MR000032-fig-0031" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-025.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-025.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.1</div> <div class="figure-caption"> <p>Comparison 25: B ‐ Monetary incentives: Addition of monetary rewards to all trial arms, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-025.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-026.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 26: B ‐ Monetary incentives: Addition of monetary incentives vs lottery, Outcome 1: Retention" data-id="MR000032-fig-0032" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-026.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-026.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.1</div> <div class="figure-caption"> <p>Comparison 26: B ‐ Monetary incentives: Addition of monetary incentives vs lottery, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-026.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-027.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 27: B ‐ Monetary incentives: Lottery vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0033" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-027.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-027.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.1</div> <div class="figure-caption"> <p>Comparison 27: B ‐ Monetary incentives: Lottery vs usual follow‐up, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-027.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-028.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 28: B ‐ Monetary incentives: Addition of lottery to both trial arms, Outcome 1: Retention" data-id="MR000032-fig-0034" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-028.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-028.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.1</div> <div class="figure-caption"> <p>Comparison 28: B ‐ Monetary incentives: Addition of lottery to both trial arms, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-028.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-029.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 29: B ‐ Non‐monetary incentives: Addition of pen vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0035" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-029.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-029.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.1</div> <div class="figure-caption"> <p>Comparison 29: B ‐ Non‐monetary incentives: Addition of pen vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-029.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-030.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 30: B ‐ Non‐monetary incentives: Addition of societal benefit message vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0036" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-030.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-030.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.1</div> <div class="figure-caption"> <p>Comparison 30: B ‐ Non‐monetary incentives: Addition of societal benefit message vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-030.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-031.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 31: B ‐ Non‐monetary incentives: Certificate of appreciation vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0037" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-031.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-031.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.1</div> <div class="figure-caption"> <p>Comparison 31: B ‐ Non‐monetary incentives: Certificate of appreciation vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-031.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-032.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 32: B ‐ Maintaining participant engagement: Newsletter vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0038" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-032.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-032.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.1</div> <div class="figure-caption"> <p>Comparison 32: B ‐ Maintaining participant engagement: Newsletter vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-032.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-033.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 33: B ‐ Maintaining participant engagement: Offer of receiving trial results vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0039" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-033.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-033.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 33.1</div> <div class="figure-caption"> <p>Comparison 33: B ‐ Maintaining participant engagement: Offer of receiving trial results vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-033.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-034.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 34: B‐ Maintaining Participant Engagement: Cover letter including a social incentive vs standard cover letter, Outcome 1: Retention" data-id="MR000032-fig-0040" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-034.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-034.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 34.1</div> <div class="figure-caption"> <p>Comparison 34: B‐ Maintaining Participant Engagement: Cover letter including a social incentive vs standard cover letter, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-034.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-035.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 35: B ‐ Maintaining participant engagement: Varying signatory on cover letter, Outcome 1: Retention" data-id="MR000032-fig-0041" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-035.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-035.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.1</div> <div class="figure-caption"> <p>Comparison 35: B ‐ Maintaining participant engagement: Varying signatory on cover letter, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-035.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-036.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 36: B ‐ Maintaining participant engagement: Addition of a deadline vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0042" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-036.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-036.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 36.1</div> <div class="figure-caption"> <p>Comparison 36: B ‐ Maintaining participant engagement: Addition of a deadline vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-036.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-037.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 37: B ‐ Maintaining participant engagement: Addition of an estimate of time to complete vs no addition, Outcome 1: Retention" data-id="MR000032-fig-0043" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-037.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-037.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.1</div> <div class="figure-caption"> <p>Comparison 37: B ‐ Maintaining participant engagement: Addition of an estimate of time to complete vs no addition, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-037.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-038.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 38: B. Maintaining participant engagement: Brown vs white envelope, Outcome 1: Retention" data-id="MR000032-fig-0044" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-038.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-038.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 38.1</div> <div class="figure-caption"> <p>Comparison 38: B. Maintaining participant engagement: Brown vs white envelope, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-038.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-039.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 39: B ‐ Maintaining participant engagement: Post‐it note vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0045" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-039.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-039.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.1</div> <div class="figure-caption"> <p>Comparison 39: B ‐ Maintaining participant engagement: Post‐it note vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-039.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-040.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 40: B ‐ Maintaining participant engagement: Inclusion of trial newspaper article vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0046" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-040.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-040.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.1</div> <div class="figure-caption"> <p>Comparison 40: B ‐ Maintaining participant engagement: Inclusion of trial newspaper article vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-040.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-041.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 41: B. Maintaining participant engagement: Frequency of telephone contact, Outcome 1: Retention" data-id="MR000032-fig-0047" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-041.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-041.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 41.1</div> <div class="figure-caption"> <p>Comparison 41: B. Maintaining participant engagement: Frequency of telephone contact, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-041.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-042.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 42: B ‐ Maintaining participant engagement: Request for collateral (concomitant), Outcome 1: Retention" data-id="MR000032-fig-0048" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-042.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-042.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 42.1</div> <div class="figure-caption"> <p>Comparison 42: B ‐ Maintaining participant engagement: Request for collateral (concomitant), Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-042.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-043.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 43: B ‐ Behavioural interventions: Theory informed cover letter vs usual cover letter, Outcome 1: Retention" data-id="MR000032-fig-0049" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-043.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-043.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 43.1</div> <div class="figure-caption"> <p>Comparison 43: B ‐ Behavioural interventions: Theory informed cover letter vs usual cover letter, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-043.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-044.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 44: B ‐ Behavioural interventions: Motivational interviewing vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0050" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-044.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-044.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 44.1</div> <div class="figure-caption"> <p>Comparison 44: B ‐ Behavioural interventions: Motivational interviewing vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-044.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-045.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 45: C ‐ Prompts: Site prompts for upcoming assessments vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0051" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-045.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-045.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 45.1</div> <div class="figure-caption"> <p>Comparison 45: C ‐ Prompts: Site prompts for upcoming assessments vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-045.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-046.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 46: C ‐ Monitoring visits: On‐site monitoring vs no visits, Outcome 1: Retention" data-id="MR000032-fig-0052" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-046.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-046.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 46.1</div> <div class="figure-caption"> <p>Comparison 46: C ‐ Monitoring visits: On‐site monitoring vs no visits, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-046.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-047.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 47: D ‐ Patient Public Involvement: Peer‐led follow‐up strategy vs usual follow‐up, Outcome 1: Retention" data-id="MR000032-fig-0053" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-047.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-047.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 47.1</div> <div class="figure-caption"> <p>Comparison 47: D ‐ Patient Public Involvement: Peer‐led follow‐up strategy vs usual follow‐up, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-047.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-048.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 48: E ‐ Impact of recruitment: Video‐enhanced patient information vs standard information, Outcome 1: Retention" data-id="MR000032-fig-0054" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-048.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-048.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 48.1</div> <div class="figure-caption"> <p>Comparison 48: E ‐ Impact of recruitment: Video‐enhanced patient information vs standard information, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-048.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-049.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 49: E ‐ Impact of recruitment: Optimised information vs standard information, Outcome 1: Retention" data-id="MR000032-fig-0055" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-049.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-049.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 49.1</div> <div class="figure-caption"> <p>Comparison 49: E ‐ Impact of recruitment: Optimised information vs standard information, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-049.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-050.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 50: E ‐ Impact of recruitment: Addition of optimised information to both arms, Outcome 1: Retention" data-id="MR000032-fig-0056" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-050.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-050.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 50.1</div> <div class="figure-caption"> <p>Comparison 50: E ‐ Impact of recruitment: Addition of optimised information to both arms, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-050.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-051.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 51: E ‐ Impact of recruitment: Pen vs no pen, Outcome 1: Retention" data-id="MR000032-fig-0057" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-051.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-051.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 51.1</div> <div class="figure-caption"> <p>Comparison 51: E ‐ Impact of recruitment: Pen vs no pen, Outcome 1: Retention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-051.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000032-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/urn:x-wiley:14651858:media:MR000032:MR000032-CMP-052.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 52: E ‐ Blinding and treatment preference: Open vs blind trial design, Outcome 1: Retention" data-id="MR000032-fig-0058" src="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-052.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_t/tMR000032-CMP-052.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 52.1</div> <div class="figure-caption"> <p>Comparison 52: E ‐ Blinding and treatment preference: Open vs blind trial design, Outcome 1: Retention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/media/CDSR/MR000032/image_n/nMR000032-CMP-052.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Questionnaire design: short vs usual questionnaire</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short questionnaire compared with long questionnaire for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> short questionnaire </p> <p><b>Comparison:</b> usual questionnaire </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Short questionnaire</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual questionnaire</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>As measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.01</b> (0.89 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3252<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(22 to 29 ) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(45 to 57) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 100</b><br/>(71 to 91) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of a short questionnaire</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Questionnaire design: short vs usual questionnaire</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Questionnaire design: addition of diary to usual follow‐up vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Addition of diary to usual follow‐up compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> diary </p> <p><b>Comparison:</b> no diary </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Diary</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No diary</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.97</b> (0.96 to 0.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>9906<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 100</b><br/>(24 to 25) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 100</b><br/>(48 to 49) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>78 per 100</b><br/>(77 to 78) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of not including a diary</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup>We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Questionnaire design: addition of diary to usual follow‐up vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Data collection location and method: telephone follow‐up vs postal questionnaire</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Telephone follow‐up compared with postal questionnaire for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> telephone follow‐up </p> <p><b>Comparison:</b> postal questionnaire </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Telephone follow‐up</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Postal questionnaire</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.04</b> (0.94 to 1.17) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1006<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(24 to 29) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>52 per 100</b><br/>(47 to 59) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 100</b><br/>(75 to 94) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of telephone follow‐up</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Data collection location and method: telephone follow‐up vs postal questionnaire</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Data collection location and method: return postage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Return postage compared with control intervention for trial retention</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> various return postage strategies </p> <p><b>Comparison:</b> control intervention </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p>Various return postage strategies <b>(such as free post versus second class stamp; high priority mail stamp versus usual postage; and personal form)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard return postage</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.06</b> (0.99 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1543<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 100</b><br/>(25 to 29) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>53 per 100</b><br/>(50 to 58) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 100</b><br/>(79 to 92) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Data collection location and method: return postage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Reminders: electronic reminder vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Electronic reminder compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> electronic reminder </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Electonic reminder</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.01</b> (0.95 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>790<br/>(3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(24 to 27) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(48 to 55) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 100</b><br/>(76 to 87) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of an electronic reminder</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Reminders: electronic reminder vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Prompts: Electronic prompt vs no prompt</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Electronic prompt compared with no prompt for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> electronic prompt </p> <p><b>Comparison:</b> no prompt </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Electronic prompt</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No prompt</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.03</b> (0.98 to 1.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>2897<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(25 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>52 per 100</b><br/>(49 to 54) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(78 to 86) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of electronic prompts</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Prompts: Electronic prompt vs no prompt</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Prompts: Telephone prompt vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Telephone prompt compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> telephone prompt </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Telephone prompt</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.02</b> (0.85 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>943<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(21 to 31) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(43 to 61) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(68 to 98) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of telephone prompts</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Prompts: Telephone prompt vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Prompts: personalised prompt vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Personalised prompt compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> personalised prompt </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Personalised prompt</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.97</b> (0.89 to 1.07) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>701<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 100</b><br/>(22 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 100</b><br/>(45 to 54) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>78 per 100</b><br/>(71 to 86) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of personalised prompts</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Prompts: personalised prompt vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Monetary incentives: addition of monetary incentives vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Addition of monetary incentives compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> monetary incentives </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary incentives</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.20</b> (1.06 to 1.36) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3166<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 100</b><br/>(27 to 34) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b><br/>(53 to 68) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>96 per 100</b><br/>(85 to [109) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of monetary incentives</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Monetary incentives: addition of monetary incentives vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0010"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Monetary incentives: addition of monetary incentives vs addition of a monetary reward</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Addition of monetary incentives compared with addition of a monetary reward for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> monetary incentive </p> <p><b>Comparison:</b> monetary reward </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary incentive</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary reward</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.00</b> (0.91 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3765<br/>(4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(23 to 28) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b><br/>(46 to 55) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b><br/>(73 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Monetary incentives: addition of monetary incentives vs addition of a monetary reward</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0011"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Monetary incentives: addition of monetary reward vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Addition of monetary reward compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> monetary reward </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Monetary reward</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.02</b> (0.96 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1159<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(24 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>(48 to 55) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(77 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of monetary reward</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Monetary incentives: addition of monetary reward vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0012"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Non‐monetary incentives: addition of pen vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Pen compared with no pen for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> pen </p> <p><b>Comparison:</b> no pen </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Pen</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No pen</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.02</b> (1.00 to 1.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>13013<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(25 to 26) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b><br/>50 to 53) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b><br/>(80 to 84) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Non‐monetary incentives: addition of pen vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0013"> <div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">Maintaining participant engagement: newsletter vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Newsletter compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> newsletter </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Newsletter</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.99</b> (0.95 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>5622<br/>(4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(24 to 26) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b><br/>(48 to 52) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 100</b><br/>(76 to 83) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">Maintaining participant engagement: newsletter vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0014"> <div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">Maintaining participant engagement: post‐it note vs usual follow‐up</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Post‐it note compared with usual follow‐up for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> post‐it note </p> <p><b>Comparison:</b> usual follow‐up </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Post‐it note</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual follow‐up</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.00</b> (0.99 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>4698<br/>(3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b><br/>(25 to 25) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b><br/>(50 to 51) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b><br/>(79 to 81) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of a post‐it note</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">Maintaining participant engagement: post‐it note vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0015"> <div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">Behavioural interventions: theory informed cover letter vs usual cover letter</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Theory informed cover letter compared with usual cover letter for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> theory informed cover letter </p> <p><b>Comparison:</b> usual cover letter </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Theory informed cover letter</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual cover letter</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.05</b> (0.98 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>3343<br/>(4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b><br/>(25 to 28) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>53 per 100</b><br/>(49 to 56) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 100</b><br/>(78 to 90) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>effect of a theory informed cover letter</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">Behavioural interventions: theory informed cover letter vs usual cover letter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000032-tbl-0016"> <div class="table-heading"><span class="table-label">Summary of findings 16.</span> <span class="table-title">Impact of recruitment: optimised information vs standard information</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Addition of optimised information compared with standard information for trial retention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> trial participants being followed up for data collection </p> <p><b>Settings:</b> any setting </p> <p><b>Intervention:</b> optimised patient information leaflet (PIL) </p> <p><b>Comparison:</b> standard PIL </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Optimised PIL</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard PIL</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Retention</b> </p> <p>[follow‐up]</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.96</b> (0.85 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>1285<br/>(2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 100</b><br/>(21 to 27) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 100</b><br/>(43 to 55) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 100</b><br/>(68 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><sup>a</sup> We selected low, medium and high illustrative retention levels of 25%, 50% and 80% based on prior experience with trial retention and evidence from the literature. For example, it has been previously stated that it is common for up to 20% trial participants to drop out before the trial finishes (<a href="./references#MR000032-bbs2-0212" title="WalshM , SackettD , DeverauxPJ . When RCT participants are lost to follow up. Why even a few can matter. Clinical Trials2015;12:537?9. [DOI: 10.1177/1740774515597702]">Walsh 2015</a>), as such we set the upper limit of good retention as 80%. The other extreme of 25% was informed by evidence that some trials (largely internet based) can have retention as low as 10% to 25% (<a href="./references#MR000032-bbs2-0199" title="MurrayE , KhadjesariZ , WhiteIR , KalaitzakiE , GodfreyC , McCambridgeJ , et al. Methodological challenges in online trials.. Journal of Medical Internet Research2009;11(2):e9. [DOI: 10.2196/jmir.1052]">Murray 2009</a>). The mid point of 50% was a judgement made by the review team and was deemed appropriate given the evidence for the other parameters. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 16.</span> <span class="table-title">Impact of recruitment: optimised information vs standard information</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000032-tbl-0017"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Countries where the included studies took place</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Country</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norway</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Multinational</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (one involving UK and Ireland and one involving the USA and Canada).</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Countries where the included studies took place</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000032-tbl-0018"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Data collection (Category A)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sub‐domains</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>1A. Questionnaire design: Questionnaire length</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#MR000032-bbs2-0021" title="DormanP , SlatteryJ , FarrellB , DennisMS , SandercockPA . A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial. BMJ1997;315(7106):461. ">Dorman 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New questionnaire</p> <p>(Shorter version)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#MR000032-bbs2-0022" title="EdwardsP , RobertsI , SandercockP , FrostC . Follow-up by mail in clinical trials: does questionnaire length matter?Controlled Clinical Trials2004;25(1):31-52. [DOI: 10.1016/j.cct.2003.08.013]">Edwards 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New questionnaire</p> <p>(Shorter version)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subar 2001</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New questionnaire</p> <p>(Shorter version)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>2A. Questionnaire design: Addition of a diary to usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Griffin 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diaries follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal questionnaires follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marques2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resource use log to prospectively record their use of health services</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No resource use log</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>3A. Questionnaire design: Question order, condition first vs generic first question</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>McColl 2003</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Condition‐specific measures of quality of life preceded generic instruments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Questionnaires in a reverse order</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>4A. Data collection frequency and timing: Timing of questionnaire delivery</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renfroe 2002</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of postal questionnaire, cover letter signatory, express</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Regular mail, non‐monetary incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>5A. Data Collection Location and Method: Postal follow‐up vs clinic follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greig 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>6A. Data Collection Location and Method: Telephone follow‐up vs postal questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Couper 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Postal trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up with an incentive</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Telephone trail)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up with an incentive</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>7A. Data Collection Location and Method: First class vs second class outward mailing</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sharp 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>First‐class post</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Second class</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>8A. Data Collection Location and Method: Return postage</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sharp 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Preaddressed second class stamped envelope</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Business reply envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenton 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'high priority' stamp to the mailing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Business format mailing</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dinglas 2015 (Mail trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised postal follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Generic postal follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>9A. Data Collection Location and Method: Use of self‐sampling kits</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranberg 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a modified second reminder, a leaflet, and a self‐sampling kit.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>received the same material as those in the directly mailed group but received no kit</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Data collection (Category A)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000032-tbl-0019"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Participants (Category B)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sub‐domains</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>10B. Reminders: electronic reminder vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ashby 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Additional electronic reminder in follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (Email reminder)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Email reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal email reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (SMS text pre‐notification)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prenotification reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>11B. Reminders: action oriented electronic reminder vs standard electronic reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (photo trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The personalised photo on the letter</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (pre‐call trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>12B. Reminders: personalised reminder vs non‐personalised reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nakash2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calendar</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message the day before the email with the link to the questionnaire. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No SMS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>13B. Reminders: telephone reminder vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severi 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone call reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>14B. Reminders: telephone reminder vs postal reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tai 1997</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>15B. Prompts: electronic prompt vs no prompt</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message and a further £10 high‐street shopping voucher sent by post before the 24 months visit. </p> <p>Intervention group 2 received a further £10 high‐street shopping voucher given at the visit. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clark 2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received an SMS or e‐mail to return a study questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no electronic prompt to returns a study questionnaire</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Keding 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Text message prompt</p> <p>Prompt</p> <p>Reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> <p>Reminder</p> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Man 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electronic reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (Email reminder)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Email reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal email reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Starr 2015 (SMS text pre‐notification)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prenotification reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>16B. Prompts: telephone prompt vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (Email trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of an email as prompt</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual Follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MacLennan 2014</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a telephone call from the trial office ahead of the reminder questionnaire in addition to the usual reminder schedule </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received the usual reminder schedule only</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>17B. Prompts: Prenotification card vs no card</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treweek 2020a</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐notification card sent around 1 month before</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pre‐notification card</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>18B. Prompts: sticker vs no sticker</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a logo sticker on questionnaire envelopes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no sticker</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>19B. Prompts: personalised prompt vs no prompt</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐personalised reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised text message</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No personalised text message</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nakash 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calendar</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>20B. Monetary incentives: addition of monetary incentives vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bauer 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions group 1 received an incentive of US$10</p> <p>Interventions group 2 received an incentive of US$2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gates 2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>£5 gift voucher</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no gift voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenyon 2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Monetary incentive (£5 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>21B. Monetary incentives: addition of monetary incentives to all trial arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bauer 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions group 1 received an incentive of US$10</p> <p>Interventions group 2 received an incentive of US$2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message and a further £10 high‐street shopping voucher sent by post before the 24‐month visit. </p> <p>Intervention group 2 received a further £10 high‐street shopping voucher given at the visit. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>22B. Monetary incentives: addition of monetary incentives vs addition of monetary reward </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradshaw 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group 1 received an SMS message and a further £10 high‐street shopping voucher sent by post before the 24 months visit. </p> <p>Intervention group 2 received a further £10 high‐street shopping voucher given at the visit. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cook 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>£20 gift voucher given to study at the end of the recruitment visit</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A conditional offer of monetary incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dorling 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received the first paper letter to parents included a promise of an incentive (£15 gift voucher redeemable at some shops) after receipt of a completed form. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received the first paper letter to parents would enclose the incentive (£15 gift voucher redeemable at high‐street shops) before the receipt of a completed form </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Young 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of monetary incentive (£5 multistore voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of incentive (i.e. Conditional vs unconditional £5 multistore voucher)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>23B. Monetary incentives: addition of monetary reward vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Clinic trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic visit with an incentive (£2 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic visit without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Postal trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up with incentive (£2 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postal follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marsh 1999 (Telephone trail)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up with incentive (£2 voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telephone follow‐up without incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Watson 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Intervention group 1</i> received unconditional (£5 gift voucher) at 12 but not 24 months. </p> <p><i>Intervention group 2</i> received unconditional (£5 gift voucher) at 12 and 24 months. </p> <p><i>Intervention group 3</i> received unconditional (£5 gift voucher) at 24 but not 12 months. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No voucher</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Arundel 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of conditional monetary incentive (£10 cash reliant on providing in addition to the £10 gift voucher routinely provided) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up (£10 gift voucher routinely provided)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>24B. Monetary incentives: addition of monetary rewards to all trial arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hardy 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of conditional monetary incentive (£10 gift voucher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Later offer of conditional monetary incentive (£10 gift voucher)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>25B. Monetary incentives: addition of monetary incentives vs lottery</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenton 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Monetary incentive (CAN$2 coin mailed with the questionnaire or draw for a CAN$50 gift certificate upon questionnaire receipt) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lottery</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>26B. Monetary incentives: lottery vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>No incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>27B. Monetary incentives: addition of lottery to both trial arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Henderson 2010</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An offer of winning voucher (winning 1 of 25 £20 shopping vouchers or winning one £500 shopping voucher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No incentive</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>28B. Non‐monetary incentives: addition of pen vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bell 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a pen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cunningham‐Burley 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Branded pen with their questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>James 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pen with trial invitation pack</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2020b</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a pen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sharp 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pen</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>29B. Non‐monetary incentives: addition of societal benefit message vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severi 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fridge magnet and benefit to society message</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>30B. Non‐monetary incentives: certificate of appreciation vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renfroe 2002</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of postal questionnaire, cover letter signatory, express mail</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Regular mail and non‐monetary incentive.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>31B. Maintaining participant engagement: newsletter vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a tested a theoretically informed newsletter sent before the questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no newsletter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MARMOTH trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newsletter one month before the 24‐month paper follow‐up questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No newsletter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a white envelope</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a brown envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rodgers 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newsletter + handwritten posit it notes</p> <p>Newsletter + printed posit it notes</p> <p>Newsletter only</p> <p>Handwritten posit it notes only</p> <p>Printed posit it note only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>32B. Maintaining participant engagement: offer of receiving trial results vs usual follow‐up </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cockayne 2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Offered the result of the trial in a questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No offer of knowing the results</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>33B. Maintaining participant engagement: cover letter including a social incentive vs standard cover letter </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>James 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Intervention group 1</i> received a branded pen and a standard cover letter. </p> <p><i>Intervention group 2</i> received a branded pen and a social incentive cover letter. </p> <p><i>Intervention group 3</i> received no pen and a social incentive cover letter. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Control group</i> received no pen, standard cover letter. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>34B. Maintaining participant engagement: personalised cover letter vs usual cover letter </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (Email trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of an email as prompt</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (photo trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Personalised photo on the letter</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edwards 2016 (pre‐call trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active reminder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>35B. Maintaining participant engagement: varying signatory on cover letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renfroe 2002</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of postal questionnaire, cover letter signatory, express mail</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Regular mail and non‐monetary incentive.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>36B. Maintaining participant engagement: addition of a deadline vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gatellari 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cover letter advising return within 1‐week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard cover letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>37B. Maintaining participant engagement: addition of an estimate of time to complete vs no addition </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Marson 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cover letter though post with the questionnaire that included an estimate of the length of time that it may take to complete </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard cover letter with no indication of length of time required</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>38B. Maintaining participant engagement: brown vs white envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mitchell 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a white envelope</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Invitation mailing packs with a brown envelope</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>39B. Maintaining participant engagement: post‐it notes vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lewis 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a post‐it note</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rodgers 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newsletter + handwritten posit it notes</p> <p>Newsletter + printed posit it notes</p> <p>Newsletter only</p> <p>Handwritten posit it notes only</p> <p>Printed posit it note only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tilbrook 2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addition of a post‐it note</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>40B. Maintaining participant engagement: inclusion of trial newspaper article vs usual follow‐up </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvesen 1992</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newspaper article</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>41B. Maintaining participant engagement: frequency of telephone contact</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Glassman 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received telephone calls at baseline, six months, and at annual visits after that (annual contact) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a call at baseline only (baseline contact)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>42B. Maintaining participant engagement: request for collateral (concomitant)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cunningham 2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Intervention group</i> <i>1</i> were asked to provide a collateral. </p> <p><i>Intervention group</i> <i>2</i> asked to provide collateral and told that there was a 50% chance that the collateral would be contacted. </p> <p>All those respondents asked for collateral were told that the collateral would receive a CAN$20 payment for a brief telephone interview. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not asked to provide a collateral</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>43B. Behavioural interventions: theory informed cover letter vs usual cover letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AMBER trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a tested a theoretically informed letter sent with the questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a standard letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Theory informed letter to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goulao 2020 (replication)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Theory informed letter to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual letter follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OPAL trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a tested a theoretically informed letter sent with the questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a standard letter</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>44B. Behavioural interventions: motivational interviewing vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bean 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Theory informed to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual follow‐up</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Participants (Category B)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000032-tbl-0020"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Sites and site staff (Category C)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sub‐domains</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>45C. Prompts: site prompts for upcoming assessments vs usual follow‐up</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Land 2007</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received a monthly reminder to sites listing participants who were due to have a measure in the next three months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received no reminder</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>46C. Monitoring visits: on‐site monitoring vs no visit</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lienard 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Centres received a systematic on‐site visit (Visited group)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not receive a systematic on‐site visit (Non‐visited group)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Sites and site staff (Category C)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000032-tbl-0021"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Central Study Management (Category D)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sub‐domains</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>47D. Patient Public Involvement: peer‐led follow‐up strategy vs usual follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fouad 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Peer‐led strategy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual follow‐up</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Central Study Management (Category D)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000032-tbl-0022"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Study design (Category E)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sub‐domains</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>48E. Impact of recruitment: video‐enhanced patient information vs standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brubaker 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change to information provided at recruitment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>49E. Impact of recruitment: optimised information vs standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cockayne 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Optimised patient information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard patient information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Guarino 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change to information provided at recruitment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>50E. Impact of recruitment: addition of optimised information to both arms</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cockayne 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Optimised patient information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard patient information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>51E. Impact of recruitment: pen vs no pen</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Whiteside 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐monetary incentive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual practice (at recruitment)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>52E. Blinding and treatment preference: open vs blind trial design</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Avenell 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open design</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blinded design</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Study design (Category E)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/full#MR000032-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">A ‐ Questionnaire Design: Short vs usual questionnaire</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.08, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">A ‐ Questionnaire Design: Short vs usual questionnaire</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">A ‐ Questionnaire Design: Addition of diary to usual follow up vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9906</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.04, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">A ‐ Questionnaire Design: Addition of diary to usual follow up vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">A ‐ Questionnaire Design: Question order, condition first vs generic first questions</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">A ‐ Questionnaire Design: Question order, condition first vs generic first questions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">A ‐ Data Collection Frequency and Timing: Timing of questionnaire delivery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.01, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">A ‐ Data Collection Frequency and Timing: Timing of questionnaire delivery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">A ‐ Data Collection Location and Method: Postal follow‐up vs clinic follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.08, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">A ‐ Data Collection Location and Method: Postal follow‐up vs clinic follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">A ‐ Data Collection Location and Method: Telephone follow‐up vs postal questionnaire</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Retention ‐ sensitivity analysis removing quasi‐RCTs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.04, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">A ‐ Data Collection Location and Method: Telephone follow‐up vs postal questionnaire</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">A ‐ Data Collection Location and Method: First class vs second class outward mailing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>930</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">A ‐ Data Collection Location and Method: First class vs second class outward mailing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">A ‐ Data Collection Location and Method: Return postage</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1543</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.00, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Freepost vs second class stamp</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>930</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.02, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.2 High priority mail stamp vs usual postage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.08, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.3 Personal format mailing vs business format mailing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.02, 0.19]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">A ‐ Data Collection Location and Method: Return postage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0031"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">A ‐ Data Collection Location and Method: Use of self‐sampling kits</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19582</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.04, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 Directly mailed self‐sampling kit vs invitation to order salf‐sampling kit</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6529</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.05, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.2 Directly mailed self‐sampling kit vs usual follow up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.11, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.3 Invitation to order self‐sampling vs usual follow up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.04, 0.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">A ‐ Data Collection Location and Method: Use of self‐sampling kits</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0031">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0032"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">B ‐ Reminders: Electronic reminder vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>790</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">B ‐ Reminders: Electronic reminder vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0032">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0033"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">B ‐ Reminders: Action oriented electronic reminder vs standard electronic reminder</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.10, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">B ‐ Reminders: Action oriented electronic reminder vs standard electronic reminder</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0033">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0034"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">B ‐ Reminders: Personalised reminder vs non‐personalised reminder</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.11, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">B ‐ Reminders: Personalised reminder vs non‐personalised reminder</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0034">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0035"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">B ‐ Reminders: Telephone reminder vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.18, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">B ‐ Reminders: Telephone reminder vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0035">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0036"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">B ‐ Reminders: Telephone reminder vs postal reminder</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.33, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">B ‐ Reminders: Telephone reminder vs postal reminder</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0036">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0037"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">B ‐ Prompts: Electronic prompt vs no prompt</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2897</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">B ‐ Prompts: Electronic prompt vs no prompt</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0037">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0038"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">B ‐ Prompts: Telephone prompt vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.10, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">B ‐ Prompts: Telephone prompt vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0038">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0039"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">B ‐ Prompts: Prenotification card vs no card</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.03, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">B ‐ Prompts: Prenotification card vs no card</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0039">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0040"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">B ‐ Prompts: Sticker vs no sticker</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.07, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">B ‐ Prompts: Sticker vs no sticker</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0040">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0041"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">B ‐ Prompts: Personalised prompt vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.09, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">B ‐ Prompts: Personalised prompt vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0041">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0042"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">B ‐ Prompts: Electronic prompts vs electronic reminders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>269</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.06, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">B ‐ Prompts: Electronic prompts vs electronic reminders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0042">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0043"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.04, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21.2 Retention‐ sensitivity anlysis removing quasi‐RCTs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1022</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.02, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0043">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0044"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives to all trial arms</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.03, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives to all trial arms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0044">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0045"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives vs addition of monetary reward</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.07, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives vs addition of monetary reward</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0045">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0046"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">B‐ Monetary incentives: Addition of monetary reward vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.03, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1.1 Return of postal questionnaires</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>725</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.06, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1.2 Attendance at follow up visits</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.04, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24.2 Retention ‐ sensitivity analysis removing quasi‐RCTs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>955</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2.1 Return of postal questionnaires</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.09, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2.2 Attendance at follow up visits</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.04, 0.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">B‐ Monetary incentives: Addition of monetary reward vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0046">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0047"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary rewards to all trial arms</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.03, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary rewards to all trial arms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0047">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0048"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives vs lottery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.09, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">B ‐ Monetary incentives: Addition of monetary incentives vs lottery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0048">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0049"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">B ‐ Monetary incentives: Lottery vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">B ‐ Monetary incentives: Lottery vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0049">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0050"> <div class="table-heading"><span class="table-label">Comparison 28.</span> <span class="table-title">B ‐ Monetary incentives: Addition of lottery to both trial arms</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 28.</span> <span class="table-title">B ‐ Monetary incentives: Addition of lottery to both trial arms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0050">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0051"> <div class="table-heading"><span class="table-label">Comparison 29.</span> <span class="table-title">B ‐ Non‐monetary incentives: Addition of pen vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 29.</span> <span class="table-title">B ‐ Non‐monetary incentives: Addition of pen vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0051">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0052"> <div class="table-heading"><span class="table-label">Comparison 30.</span> <span class="table-title">B ‐ Non‐monetary incentives: Addition of societal benefit message vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 30.</span> <span class="table-title">B ‐ Non‐monetary incentives: Addition of societal benefit message vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0052">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0053"> <div class="table-heading"><span class="table-label">Comparison 31.</span> <span class="table-title">B ‐ Non‐monetary incentives: Certificate of appreciation vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.13, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 31.</span> <span class="table-title">B ‐ Non‐monetary incentives: Certificate of appreciation vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0053">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0054"> <div class="table-heading"><span class="table-label">Comparison 32.</span> <span class="table-title">B ‐ Maintaining participant engagement: Newsletter vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.04, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 32.</span> <span class="table-title">B ‐ Maintaining participant engagement: Newsletter vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0054">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0055"> <div class="table-heading"><span class="table-label">Comparison 33.</span> <span class="table-title">B ‐ Maintaining participant engagement: Offer of receiving trial results vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1038</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.05, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 33.</span> <span class="table-title">B ‐ Maintaining participant engagement: Offer of receiving trial results vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0055">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0056"> <div class="table-heading"><span class="table-label">Comparison 34.</span> <span class="table-title">B‐ Maintaining Participant Engagement: Cover letter including a social incentive vs standard cover letter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.04, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 34.</span> <span class="table-title">B‐ Maintaining Participant Engagement: Cover letter including a social incentive vs standard cover letter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0056">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0057"> <div class="table-heading"><span class="table-label">Comparison 35.</span> <span class="table-title">B ‐ Maintaining participant engagement: Varying signatory on cover letter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.06, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 35.</span> <span class="table-title">B ‐ Maintaining participant engagement: Varying signatory on cover letter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0057">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0058"> <div class="table-heading"><span class="table-label">Comparison 36.</span> <span class="table-title">B ‐ Maintaining participant engagement: Addition of a deadline vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.05, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 36.</span> <span class="table-title">B ‐ Maintaining participant engagement: Addition of a deadline vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0058">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0059"> <div class="table-heading"><span class="table-label">Comparison 37.</span> <span class="table-title">B ‐ Maintaining participant engagement: Addition of an estimate of time to complete vs no addition</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1815</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.02, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 37.</span> <span class="table-title">B ‐ Maintaining participant engagement: Addition of an estimate of time to complete vs no addition</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0059">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0060"> <div class="table-heading"><span class="table-label">Comparison 38.</span> <span class="table-title">B. Maintaining participant engagement: Brown vs white envelope</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 38.</span> <span class="table-title">B. Maintaining participant engagement: Brown vs white envelope</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0060">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0061"> <div class="table-heading"><span class="table-label">Comparison 39.</span> <span class="table-title">B ‐ Maintaining participant engagement: Post‐it note vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4698</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.01, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1.1 Printed post‐it note vs no post‐it note</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.02, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1.2 Handwritten post‐it note vs no post‐it note</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1051</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.03, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1.3 Printed post‐it note vs handwritten post‐it note</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>546</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.02, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1.4 Post‐it note vs no post‐it note</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 39.</span> <span class="table-title">B ‐ Maintaining participant engagement: Post‐it note vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0061">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0062"> <div class="table-heading"><span class="table-label">Comparison 40.</span> <span class="table-title">B ‐ Maintaining participant engagement: Inclusion of trial newspaper article vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>716</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.01, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 40.</span> <span class="table-title">B ‐ Maintaining participant engagement: Inclusion of trial newspaper article vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0062">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0063"> <div class="table-heading"><span class="table-label">Comparison 41.</span> <span class="table-title">B. Maintaining participant engagement: Frequency of telephone contact</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.05, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 41.</span> <span class="table-title">B. Maintaining participant engagement: Frequency of telephone contact</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0063">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0064"> <div class="table-heading"><span class="table-label">Comparison 42.</span> <span class="table-title">B ‐ Maintaining participant engagement: Request for collateral (concomitant)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.01, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1.1 Request for a collateral vs no request</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.04, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1.2 Request for a collateral with 50% chance of use vs no request</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.09, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1.3 Request for a collateral vs Request for a collateral with 50% chance of use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.07, 0.18]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 42.</span> <span class="table-title">B ‐ Maintaining participant engagement: Request for collateral (concomitant)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0064">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0065"> <div class="table-heading"><span class="table-label">Comparison 43.</span> <span class="table-title">B ‐ Behavioural interventions: Theory informed cover letter vs usual cover letter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.02, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 43.</span> <span class="table-title">B ‐ Behavioural interventions: Theory informed cover letter vs usual cover letter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0065">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0066"> <div class="table-heading"><span class="table-label">Comparison 44.</span> <span class="table-title">B ‐ Behavioural interventions: Motivational interviewing vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.17, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 44.</span> <span class="table-title">B ‐ Behavioural interventions: Motivational interviewing vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0066">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0067"> <div class="table-heading"><span class="table-label">Comparison 45.</span> <span class="table-title">C ‐ Prompts: Site prompts for upcoming assessments vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.13, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 45.</span> <span class="table-title">C ‐ Prompts: Site prompts for upcoming assessments vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0067">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0068"> <div class="table-heading"><span class="table-label">Comparison 46.</span> <span class="table-title">C ‐ Monitoring visits: On‐site monitoring vs no visits</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.20, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 46.</span> <span class="table-title">C ‐ Monitoring visits: On‐site monitoring vs no visits</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0068">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0069"> <div class="table-heading"><span class="table-label">Comparison 47.</span> <span class="table-title">D ‐ Patient Public Involvement: Peer‐led follow‐up strategy vs usual follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.14, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 47.</span> <span class="table-title">D ‐ Patient Public Involvement: Peer‐led follow‐up strategy vs usual follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0069">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0070"> <div class="table-heading"><span class="table-label">Comparison 48.</span> <span class="table-title">E ‐ Impact of recruitment: Video‐enhanced patient information vs standard information</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.05, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 48.</span> <span class="table-title">E ‐ Impact of recruitment: Video‐enhanced patient information vs standard information</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0070">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0071"> <div class="table-heading"><span class="table-label">Comparison 49.</span> <span class="table-title">E ‐ Impact of recruitment: Optimised information vs standard information</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.13, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 49.</span> <span class="table-title">E ‐ Impact of recruitment: Optimised information vs standard information</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0071">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0072"> <div class="table-heading"><span class="table-label">Comparison 50.</span> <span class="table-title">E ‐ Impact of recruitment: Addition of optimised information to both arms</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.07, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 50.</span> <span class="table-title">E ‐ Impact of recruitment: Addition of optimised information to both arms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0072">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0073"> <div class="table-heading"><span class="table-label">Comparison 51.</span> <span class="table-title">E ‐ Impact of recruitment: Pen vs no pen</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.07, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 51.</span> <span class="table-title">E ‐ Impact of recruitment: Pen vs no pen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0073">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000032-tbl-0074"> <div class="table-heading"><span class="table-label">Comparison 52.</span> <span class="table-title">E ‐ Blinding and treatment preference: Open vs blind trial design</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52.1 Retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.04, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 52.</span> <span class="table-title">E ‐ Blinding and treatment preference: Open vs blind trial design</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000032.pub3/references#MR000032-tbl-0074">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.MR000032.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#MR000032-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#MR000032-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#MR000032-note-0010">Français</a> </li> <li class="section-language"> <a class="" href="ja#MR000032-note-0008">日本語</a> </li> <li class="section-language"> <a class="" href="ko#MR000032-note-0007">한국어</a> </li> <li class="section-language"> <a class="" href="pt#MR000032-note-0006">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#MR000032-note-0005">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000032\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000032\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000032\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000032\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000032\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000032.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000032.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.MR000032.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.MR000032.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000032.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720025816"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000032.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720025820"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000032.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df6f73a7c9368',t:'MTc0MDcyMDAyNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 